Unofficial. This site is an experimental reformatting of data published by NHS England. It is not endorsed by NHS England. Always check the official Data Uses Register before relying on anything here.

National Child Development Study (NCDS)- Tracing

University College London (UCL) · Academic

In term In term in the September 2026 edition: the latest version runs to 6 February 2028.

Reference
DARS-NIC-137864-T1P9B
Current version
v7.3
Term of current version
7 February 2025 to 6 February 2028
Start date
Before 18 January 2019
Data controller
Sole Data Controller
Commercial purposes
No
Sublicensing
No
Files released to date
8

Why the data was released

Objective for processing

University College London (UCL) requires access to NHS England data for the purpose of the National Childhood Development Study (NCDS). The study follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on.

Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of the enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50, 55 and 62. The most recent survey age 62 completed in April 2024 the data will be available for researchers to use in spring 2025.

In advance of each sweep of data collection pilot studies are conducted with members of the public of a similar age to study participants. The pilot studies test the feasibility and acceptability of all aspects of the forthcoming survey. Pilot participants are asked to provide feedback on their experience of taking part which is then used to help make decisions about protocols for the survey. In 2019, a series of in-depth interviews and focus groups were conducted with 40 NCDS participants which focused on experiences of prior participation and views on how participants would like to participate in the future. The findings from this research have been and will continue to be used to shape future decisions about the design of NCDS.

UCL's Centre for Longitudinal Studies (CLS) loses touch with participants when they move home between surveys. CLS therefore requires the latest addresses for study members so that they can be contacted and invited to continue participating in the study. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives. Failure to make contact is the most significant cause of non-participation in the study. Evidence from prior surveys confirms that when contact is re-established many participants are keen to re-engage with the study and continue to participate. The receipt of up-to-date addresses for study members helps CLS maintain contact with participants which is crucial to the ongoing success of the study.

Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). CLS will not seek to trace those participants which are flagged as permanent refusals, those cases will be removed from the matching file sent to NHS England. If a participant has died, the database will be updated to reflect this and ensure no subsequent attempts to contact will be made.

Tracing via NHS England is just one of the steps that CLS take to maintain contact with participants. In addition, CLS sends an annual mailing to participants which includes a reply slip which participants are asked to return to either confirm the contact details held or to provide updates. CLS also provides participants with ‘change of address’ cards which they are asked to return if they move. CLS also collects contact details for ‘stable contacts’ who can be contacted in the event that contact is lost with the cohort member.

The following NHS England data will be accessed:

• Demographics data - necessary so UCL can maintain contact with as large a number of study members as possible. CLS require updated addresses for study members.

The level of data will be identifiable – necessary to validate the participant's details and cross-check against the CLS database.

The data will be minimised as follows.

• Limited to data for approximately 13,000 participants of the NCDS study

UCL is the controller as the organisation responsible for ensuring that the data will only be processed for the purpose described above.

The lawful basis for processing personal data under the UK GDPR is:

Article 6(1)(e) - processing is necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller

The lawful basis for processing special category data under the UK GDPR is:

Article 9(2)(j) - processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes in accordance with Article 89(1) based on Union or Member State law which shall be proportionate to the aim pursued, respect the essence of the right to data protection and provide for suitable and specific measures to safeguard the fundamental rights and the interests of the data subject.

In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from the Confidentiality Advisory Group to access this data without consent. CLS has also received Research Ethical Committee (REC) approval for tracing participants via NHS England.

The funding is provided by the Economic and Social Research Council. The age 62 survey is also funded by the Medical Research Council (MRC), the Department for Work and Pensions (DWP) and the U.S National Institute of Health. Funding is in place till 31st May 2025 but is expected to continue beyond this.

National Centre for Social Research (NatCen) and Formara are processors acting under the instruction of UCL.

NatCen has been contracted to conduct the current Age 62 Survey. NatCen are provided with study member contact details in order to invite participants to take part in the survey. This includes data which has been supplied by NHS England for updated contact information. Formara have been contracted to send mailing to participants on behalf of CLS.

Amazon Web Services provides cloud hosting services to UCL and will store the data as contracted by UCL.

VIRTUS Data Centre provides offsite back-up services but does not process the data.

All those accessing the data supplied by NHS England are substantive employees of University College London or employees of subcontractor organisations NatCen and Formara carrying out work on behalf of UCL.

Processing activities

CLS is contracting Formara Ltd to send general mailing to CLS participants. These involve mailings on the occasion of their birthday, where CLS will send participants birthday cards, invitations to activities organised by the study as well as invitation to participate in the next sweep of data collection, etc. For this purpose CLS will share the cohort members' personal information with Formara, (name, address) these may contain some of the addresses provided by NHS England to CLS. Formara will delete all information after the activity has been completed.

The CLS at UCL will transfer data to NHS England. The data will consist of identifying details (specifically NHS Number, Date of Birth, full name, Postcode, Sex and a unique person ID) for the cohort to be linked with NHS England data.

The file supplied will only contain eligible study members who have participated in at least one wave of NCDS. It will not include study members known to have died or to have withdrawn from the study.

NHS England data will provide the relevant records from the Demographics dataset to UCL. The data will contain directly identifying data items including Full Names, NHS Number, Date of Birth, Address, Postcode, Gender which are required to facilitate contact with participants.

The data will also contain:

- CLS identifier

- Fact of Death (and embarkations)

- Date of address registration or update

- Reason for removal date

- Reason for removal

The variables requested are required for validation (verify participants' details in the event of matching errors). The 'Reason for removal date' is used to compare the address confirmation data CLS holds on their database. If CLS hold an address which has been confirmed more recently than the ‘reason for removal date’ they receive from NHS England, they will retain the address in their database but if the ‘reason for removal date’ from NHS England is later than the address confirmation date they hold then they will update their records.

CLS require identifiers in the circumstance that any discrepancies arise. This is because there are instances where CLS receive identifying details that do not accurately match the cohort member. Using the identifying details CLS will be able to assess whether the details they hold correctly associate with the participant. For example, CLS have had instances where the names they hold and NHS England hold match but the Date of Birth does not match and, in this situation, they would use NHS Number and full name to determine whether it is the correct participant.

The data will be stored on servers at UCL.

UCL uses offsite back-up services provided by VIRTUS Data Centres.

UCL stores data on the Cloud provided by Amazon Web Services.

The data file supplied by NHS England will be processed within CLS and entered into CLS’s secure confidential address database. The data will remain in the DSH at all times. Access is restricted to employees or agents of UCL, NatCen and Formara.

Formara will use the data to send mailing to participants on behalf of CLS.

All personnel accessing the data have been appropriately trained in data protection and confidentiality.

The Data will be accessed by authorised personnel via remote access.

The Controller(s) must confirm and provide evidence upon audit by NHS England that access via any remote device complies with the data security obligations within this DSA and the Data Sharing Framework Contract.

For remote access:

- Remote access will only be from secure locations situated within the territory of use (as further restricted elsewhere within the DSA if so done) stated within this DSA;

- Access controls granting users the minimum level of access required are in place;

- Remote access is only via secure connections (e.g., VPNs or secure protocols) to protect data;

- Multifactor authentication (MFA) is required for remote access;

- Device security, including up-to-date software and operating systems, antivirus software, and enabled firewalls are utilised for the remote access;

- All remote access is undertaken within the scope of the organisation’s DSPT (or other security arrangements as per this DSA) and complies with the organisation’s remote access policy.

The above applies in addition to any condition set out elsewhere within the DSA (e.g. who may carry out processing, and for what purpose).

Remote processing will be from secure locations within the UK. The data will not leave the UK at any time.

The data will always remain on the servers at UCL CLS. Personnel are prohibited from downloading or copying data to local devices.

Staff using the DSH complete annual training and regularly review data access arrangements ensuring data are only limited to those authorised to access it.

The data will not be linked with any other data. However, it will be compared with existing NCDS data.

Expected output

The addresses supplied by NHS England under this agreement will help to boost the sample size and to increase the data collection at future sweeps. The output will be the participation in the survey, for those participants who would not otherwise have participated in the data collection. As a result of the previous list clean, CLS received new contact details for 1,167 participants which were used to send mailings and invited participants to take part in the NCDS Age 62 Survey . CLS is waiting to receive information from Natcen to confirm how many of the NHS addresses provided were correct and enabled contact with the cohort members.

CLS will use newly obtained addresses to send future mailings and invitations to future surveys

The main outcome of the study is the current sweep, Age 62 which ended in March 2024. CLS intends to make the data available to researchers in spring 2025. This will be a fully documented, anonymised research dataset which will be archived with the UK Data Service to provide a strategically important resource for UK Social Science, including researchers in health and social care. For clarity, the data stored on UK Data Service does not include the NHS England data this Agreement but responses from participants of the study.

The NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high-quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey was built.

The Age 62 Survey comprised of two major components:

1) A core interview which will cover the following topics:

Health, well-being and cognition: physical health, mental health, medical care, health behaviours (e.g. smoking, drinking, diet, exercise), cognitive function.

Finances and employment: work, income, wealth (savings and debts, pensions, & housing), retirement plans & education.

Family, relationships and identity: social networks, relationships with partners, parents, children, friends, neighbourhood, social capital, social and political participation, attitudes and values, and religion.

2) A detailed biomedical assessment including measures of anthropometry, physical functioning, cardiovascular risk factors and a full range of blood tests. The central aim of this biomedical assessment is to enable new research that will inform key public health concerns.

CLS will produce a range of research outputs based on the NCDS Age 62 Survey, which CLS actively disseminate to participants, policy and practice stakeholders, and the wider scientific community. CLS also promote the data resources themselves to researchers across the public, private and third sectors, in the UK and globally. CLS offers support and advice to external researchers using NCDS data and promotes a selection of their work via CLS’s communication channels. Data and research outputs from the NCDS Age 62 Survey will be disseminated through:

• Scientific journals and pre-prints

• CLS working paper series

• Free-to-attend training workshops and webinars to support researchers across all sectors and disciplines who are interested in using the data

• Free-to-attend in-person and online research seminars open to the public

• Co-hosted events or briefings for government, parliamentary or third-sector stakeholders

• Digital communications channels, including social media, university websites, podcasts and video

• Public reports, particularly when in collaboration with third-sector partners

• Direct bilateral engagement with government department partners

• Industry newsletters

• Briefing documents provided to government department partners, third-sector organisations and other policy and practice stakeholders

• Press/media engagement

• Participant newsletters

Expected measurable benefits

The continuing success of the study will be underpinned by CLS maintaining an up to date contact details database for its participants. Submitting the cohort for up-to-date contact details and being able to keep the information for future sweeps, will allow the researchers to re-contact the participants who CLS have lost touch with and give them the opportunity to re-engage or clearly state that they wish to withdraw. It will also ensure that literature goes to the correct name and address and reduces the risk of correspondence being sent to deceased participants and causing potential distress to live relatives. The information collected during the Age 62 Survey and in future sweeps may enable researchers to uncover life course and inter-generational factors which contribute to healthy ageing among this generation, and thus to inform the development of preventative health policies across the whole of life that will expand healthy life expectancy, and reduce the burden of ill-health and disease at older ages.

Benefits reported so far

In the NCDS 55 Survey which was conducted in 2013, UCL CLS achieved a large number of interviews with participants who had been newly traced to an address supplied by NHS England. The addresses obtained in previous versions of this agreement were also very useful to invite study members (NCDS age 44) to take part and re-engage with the studies. Using addresses provided by the NHS England helped CLS to get in touch with those cohort members who would otherwise not be able to take part in a new survey. Addresses obtained prior to the latest sweep age 62 , were also useful to invite participants to take part in this sweep.

The NCDS age 55 data is now available for researchers to access via the UK Data Service, providing an important resource for UK Social Science, including researchers in health and social care. https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=5560

Age 62 survey will be available via the UKDS in the spring 2025

Datasets on the current version

Legal basis for provision: Health and Social Care Act 2012 - s261(5)(d)

Datasets approved under DARS-NIC-137864-T1P9B-v7.3
DatasetType of dataSensitivity FrequencyConfidential data
Demographics Identifiable Sensitive Ongoing Section 251 NHS Act 2006
MRIS - List Cleaning Report Identifiable Sensitive One-Off Section 251 NHS Act 2006

Files released

Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.

Patient opt-outs were applied to all 8 files released under this agreement, across every version. About opt-outs

Files released against version 7.3 of this agreement, summarised by dataset.

Files released under DARS-NIC-137864-T1P9B-v7.3
DatasetFilesFirst releasedLast releasedOpt-outs applied
Demographics1 December 2025December 2025Yes

Version history

The register lists each renewal of this agreement as a separate row. This site has 6 versions — earlier versions existed before this site's records begin.

DARS-NIC-137864-T1P9B-v7.3 7 February 2025 to 6 February 2028
Title
National Child Development Study (NCDS)- Tracing
Commercial
No
Sublicensing
No
Datasets
2
Files released
1

Datasets: Demographics; MRIS - List Cleaning Report

What changed from DARS-NIC-137864-T1P9B-v6.6

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-137864-T1P9B-v6.6
FieldWasBecame
Start date2023-05-222025-02-07
End date2026-01-172028-02-06

Objective for processing

[1 paragraph unchanged] Since 1958 information has been gathered from the NCDS cohort on nine [45 words unchanged] development and other wider factors at ages 23, 33, 42, 44, 46, 50 50, 55 and 55. 62. The most recent survey commenced age 62 completed in 2020 when participants were aged 62. However, it was paused due April 2024 the data will be available for researchers to the pandemic, but this is now underway once again with an estimated end date of June 2023. use in spring 2025. In advance of each sweep of data collection pilot studies are conducted with members of the public of a similar age to study participants. The pilot studies test the feasibility and acceptability of all aspects of the forthcoming survey. Pilot participants are asked to provide feedback on their experience of taking part which is then used to help make decisions about protocols for the survey. In 2019, a series of in-depth interviews and focus groups were conducted with 40 NCDS participants which focused on experiences of prior participation and views on how participants would like to participate in the future. The findings from this research have been and will continue to be used to shape future decisions about the design of NCDS. [9 paragraphs unchanged] The lawful basis for processing personal data under the UK GDPR is Article 6(1)(e) - processing is necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller; is: The lawful basis for processing special category data under UK GDPR is Article 9(2)(j) processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes. In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from cohort members to access and link their routine health records to their survey data, and to the onward sharing of this linked data in pseudonymised form (via a secure setting with appropriate safeguards). Article 6(1)(e) - processing is necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from the Confidentiality Advisory Group to access this data without consent. CLS has also received Research Ethical Committee (REC) approval for tracing participants. The lawful basis for processing special category data under the UK GDPR is: Article 9(2)(j) - processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes in accordance with Article 89(1) based on Union or Member State law which shall be proportionate to the aim pursued, respect the essence of the right to data protection and provide for suitable and specific measures to safeguard the fundamental rights and the interests of the data subject. In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from the Confidentiality Advisory Group to access this data without consent. CLS has also received Research Ethical Committee (REC) approval for tracing participants via NHS England. [1 paragraph unchanged] National Centre for Social Research (NatCen) and Kantar Public are processors acting under the instruction of UCL. NatCen has been contracted to conduct the current Age 62 Survey. NatCen has in turn sub-contracted some of the data collection to Kantar Public. NatCen and Kantar are provided with study member contact details in order to invite participants to take part in the survey. This includes data which has been supplied by NHS England for updated contact information. National Centre for Social Research (NatCen) and Formara are processors acting under the instruction of UCL. NatCen has been contracted to conduct the current Age 62 Survey. NatCen are provided with study member contact details in order to invite participants to take part in the survey. This includes data which has been supplied by NHS England for updated contact information. Formara have been contracted to send mailing to participants on behalf of CLS. [2 paragraphs unchanged] All those accessing the data supplied by NHS England are substantive employees of University College London or employees of subcontractor organisations (NatCen /Kantar) NatCen and Formara carrying out work on behalf of UCL. In advance of each sweep of data collection pilot studies are conducted with members of the public of a similar age to study participants. The pilot studies test the feasibility and acceptability of all aspects of the forthcoming survey. Pilot participants are asked to provide feedback on their experience of taking part which is then used to help make decisions about protocols for the survey. In 2019, a series of in-depth interviews and focus groups were conducted with 40 NCDS participants which focused on experiences of prior participation and views on how participants would like to participate in the future. The findings from this research have been and will continue to be used to shape future decisions about the design of NCDS.

Processing activities

The CLS at UCL will transfer data to NHS England. The data will consist of identifying details (specifically NHS Number, Date of Birth, full name, Last Known Address, Postcode, Sex and a unique person ID) for the cohort to be linked with NHS England data. CLS is contracting Formara Ltd to send general mailing to CLS participants. These involve mailings on the occasion of their birthday, where CLS will send participants birthday cards, invitations to activities organised by the study as well as invitation to participate in the next sweep of data collection, etc. For this purpose CLS will share the cohort members' personal information with Formara, (name, address) these may contain some of the addresses provided by NHS England to CLS. Formara will delete all information after the activity has been completed. The CLS at UCL will transfer data to NHS England. The data will consist of identifying details (specifically NHS Number, Date of Birth, full name, Postcode, Sex and a unique person ID) for the cohort to be linked with NHS England data. [1 paragraph unchanged] NHS England data will provide the relevant records from the Demographics dataset to UCL. The data will contain directly identifying data items including Full Names, NHS Number, Date of Birth, Address, Postcode, Gender which are required to facilitate contact with participants. [11 paragraphs unchanged] The data file supplied by NHS England will be processed within CLS and entered into CLS’s secure confidential address database. The data will remain in the DSH at all times. Access is restricted to employees or agents of UCL, NatCen and Formara. Formara will use the data to send mailing to participants on behalf of CLS. All personnel accessing the data have been appropriately trained in data protection and confidentiality. [1 paragraph unchanged] The data file supplied by NHS England will be processed within CLS and entered into CLS’s secure confidential address database. The data will remain in the DSH at all times. Access is restricted to employees or agents of UCL, NatCen and Kantar. The Controller(s) must confirm and provide evidence upon audit by NHS England that access via any remote device complies with the data security obligations within this DSA and the Data Sharing Framework Contract. Addresses will be used by Natcen and Kantar Public to invite study members to take part in the current survey and future surveys. For remote access: No other data will be linked to the NHS England data received. - Remote access will only be from secure locations situated within the territory of use (as further restricted elsewhere within the DSA if so done) stated within this DSA; All personnel accessing the data have been appropriately trained in data protection and confidentiality. - Access controls granting users the minimum level of access required are in place; Staff using the DSH complete annual training and regularly review data access arrangements ensuring data are only limited to those authorised to access it. Personnel are prohibited from downloading or copying data to local devices. - Remote access is only via secure connections (e.g., VPNs or secure protocols) to protect data; The data will not leave the UK at any time. - Multifactor authentication (MFA) is required for remote access; - Device security, including up-to-date software and operating systems, antivirus software, and enabled firewalls are utilised for the remote access; - All remote access is undertaken within the scope of the organisation’s DSPT (or other security arrangements as per this DSA) and complies with the organisation’s remote access policy. The above applies in addition to any condition set out elsewhere within the DSA (e.g. who may carry out processing, and for what purpose). Remote processing will be from secure locations within the UK. The data will not leave the UK at any time. The data will always remain on the servers at UCL CLS. Personnel are prohibited from downloading or copying data to local devices. Staff using the DSH complete annual training and regularly review data access arrangements ensuring data are only limited to those authorised to access it. [1 paragraph unchanged] If cohort members confirm their address this will be recorded on the CLS database as a confirmed address. If the letter is ‘returned to sender’ this will also be recorded on the CLS database. There will also be cases where no confirmation is received and their letter is not returned to sender. Before the commencement of fieldwork for the Age 62 Survey – a ‘sample file’ will be sent to NatCen which will include the names and addresses of all cohort members to be invited to participate in the forthcoming survey. The sample file will include names and addresses for all study members with a confirmed address AND those addresses supplied by NHS England which were neither confirmed nor returned to sender. On some occasions, addresses with a 'return to sender’ flag will also be sent to NatCen depending on the cohort member's previous participation.

Expected output

The addresses supplied by NHS England under this agreement will help to [40 words unchanged] previous list clean, CLS received new contact details for 1,167 participants which have been were used to send mailings and invite invited participants to take part in the current NCDS Age 62 Survey. Following Survey . CLS is waiting to receive information from Natcen to confirm how many of the new list clean CLS will use newly obtained NHS addresses to send future mailings provided were correct and invitations to future surveys enabled contact with the cohort members. The main outcome of the study is the next sweep, Age 62 currently underway and scheduled to complete in 2023. This will be a fully documented, anonymised research dataset which will be archived with the UK Data Service to provide a strategically important resource for UK Social Science, including researchers in health and social care. For clarity, the data stored on UK Data Service does not include the NHS England data this Agreement but responses from participants of the study. CLS will use newly obtained addresses to send future mailings and invitations to future surveys With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high-quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build. The main outcome of the study is the current sweep, Age 62 which ended in March 2024. CLS intends to make the data available to researchers in spring 2025. This will be a fully documented, anonymised research dataset which will be archived with the UK Data Service to provide a strategically important resource for UK Social Science, including researchers in health and social care. For clarity, the data stored on UK Data Service does not include the NHS England data this Agreement but responses from participants of the study. The Age 62 Survey will be comprised of two major components: The NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high-quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey was built. The Age 62 Survey comprised of two major components: [18 paragraphs unchanged]

Benefits reported

In the NCDS 55 Survey which was conducted in 2013, UCL CLS [45 words unchanged] with the studies. Using addresses provided by the NHS England helped CLS to get in touch with those cohort members who would otherwise not be able to take part in a new survey. Addresses obtained prior to the latest sweep age 62 , were also useful to invite participants to take part in this sweep. The NCDS age 55 data is now available for researchers to access via the UK Data [5 words unchanged] for UK Social Science, including researchers in health and social care. https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=5560 Age 62 survey will be available via the UKDS in the spring 2025

Unchanged: Expected measurable benefits.

DARS-NIC-137864-T1P9B-v6.6 22 May 2023 to 17 January 2026
Title
National Child Development Study (NCDS)- Tracing
Commercial
No
Sublicensing
No
Datasets
2
Files released
2

Datasets: Demographics; MRIS - List Cleaning Report

What changed from DARS-NIC-137864-T1P9B-v5.4

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-137864-T1P9B-v5.4
FieldWasBecame
TitleMR1450 - National Child Development Study (NCDS)National Child Development Study (NCDS)- Tracing
Start date2022-01-182023-05-22
End date2023-01-172026-01-17
Demographics: legal basisHealth and Social Care Act 2012 – s261(7)Health and Social Care Act 2012 - s261(5)(d)
MRIS - List Cleaning Report: legal basisHealth and Social Care Act 2012 – s261(7)Health and Social Care Act 2012 - s261(5)(d)

Objective for processing

This Data Sharing Agreement permits the retention of the data provided under previous iterations of this Agreement. No new data flows between NHS Digital and University College London (UCL) will take place under this Agreement. The following describes the purposes for which data was supplied under previous versions of this Agreement. University College London (UCL) requires access to NHS England data for the purpose of the National Childhood Development Study (NCDS). The study follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on. The National Child Development Study (NCDS) is the second of Britain’s world renowned national longitudinal birth cohort studies. It follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on. The study has its origins in the Perinatal Mortality Survey. Sponsored by the National Birthday Trust Fund, this was designed to examine the social and obstetric factors associated with stillbirth and death in early infancy among the children born in Great Britain in that one week. Information was gathered from 17,415 babies. Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of the enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50 and 55. The most recent survey commenced in 2020 when participants were aged 62. However, it was paused due to the pandemic, but this is now underway once again with an estimated end date of June 2023. Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50 and 55. The next NCDS survey will take place in 2020 when study members will be aged 62. UCL's Centre for Longitudinal Studies (CLS) loses touch with participants when they move home between surveys. CLS therefore requires the latest addresses for study members so that they can be contacted and invited to continue participating in the study. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives. Failure to make contact is the most significant cause of non-participation in the study. Evidence from prior surveys confirms that when contact is re-established many participants are keen to re-engage with the study and continue to participate. The receipt of up-to-date addresses for study members helps CLS maintain contact with participants which is crucial to the ongoing success of the study. In 1958, when the birth survey was carried out, consent to participate in surveys was gained by respondents agreeing to be interviewed or respondents returning the completed questionnaire to the study team. Involvement in subsequent surveys adopted the same approach. Individuals could withdraw from the study at any time by simply expressing the wish to do so. Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). CLS will not seek to trace those participants which are flagged as permanent refusals, those cases will be removed from the matching file sent to NHS England. If a participant has died, the database will be updated to reflect this and ensure no subsequent attempts to contact will be made. In all recent follow-ups the approach to collecting consent has been very similar. During fieldwork, study members were sent an advance letter advising them about the survey. The letter was accompanied by an information leaflet explaining what is involved. Study members had the opportunity to request further information, or to opt out of the survey at this point. They could also seek further information, or refuse further involvement when the interviewer attempted to make an appointment to visit; when the interviewer visited and at any point during the administration of any elements of the surveys. Tracing via NHS England is just one of the steps that CLS take to maintain contact with participants. In addition, CLS sends an annual mailing to participants which includes a reply slip which participants are asked to return to either confirm the contact details held or to provide updates. CLS also provides participants with ‘change of address’ cards which they are asked to return if they move. CLS also collects contact details for ‘stable contacts’ who can be contacted in the event that contact is lost with the cohort member. Of the approximately 17415 individuals that have ever participated in the study there will always be a number of individuals for whom the Centre for Longitudinal Studies (CLS) at University College London will not have a confirmed addresses at the time of carrying out the next survey. For example, In the most recent tracing exercise conducted with NHS Digital - CLS sent just under 3,500 study members for matching. It is estimated that the number of study members which will be sent for matching in the next exercise will be lower than this. The following NHS England data will be accessed: The ongoing success of the study depends on maintaining contact with as large a number of study members as possible. Therefore, CLS are seeking permission to be supplied with updated addresses for these study members whose whereabouts are currently unknown. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives. • Demographics data - necessary so UCL can maintain contact with as large a number of study members as possible. CLS require updated addresses for study members. Objective: The level of data will be identifiable – necessary to validate the participant's details and cross-check against the CLS database. Each year CLS sends an annual birthday card postal mailing in March to all NCDS participants. CLS asks that participants complete a ‘reply slip’ which is returned to CLS which allows participants to provide CLS with any change in their details e.g. a new email address, phone number, etc. CLS also ask them to return the reply slip even if none of their details have changed i.e. seeking a positive confirmation that that is the address CLS hold for them. The data will be minimised as follows. As a result CLS, can maintain the cohorts' latest details on the NCDS database. In the event of the birthday card not reaching the participant it is returned to CLS as a ‘return to sender’. CLS will attempt to trace all these returns – but if CLS cannot locate the participants then they are flagged on the database as a ‘gone-away’. It is these cases that are being sent to NHS Digital for list cleaning as the NHS may potentially hold a more recent address and provide CLS with an opportunity to invite the cohort to re-join the study. • Limited to data for approximately 13,000 participants of the NCDS study NHS Digital will supply new addresses for untraced study members who can be matched to the NHS Central Registry/Personal Demographics Service (PDS). UCL is the controller as the organisation responsible for ensuring that the data will only be processed for the purpose described above. CLS require to trace lost study members between now and the Age 62 survey in 2020 which is currently in the planning stage. Any study members successfully traced via this route would be written to and asked to provide updated contact details. They will then subsequently be invited to participate in the NCDS Age 62 survey (unless they withdraw from the study). The lawful basis for processing personal data under the UK GDPR is Article 6(1)(e) - processing is necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller; All those the researchers would seek to trace have participated in at least one prior sweep of the study and none have ever informed CLS that they no longer wish to participate in the study. The researchers feel that a substantial number of these individuals would be willing to participate in the study if they could be contacted. Previous efforts to re-establish contact for other cohort studies have been very successful using this route. When the cohort are contacted they will be given the opportunity to withdraw. The lawful basis for processing special category data under UK GDPR is Article 9(2)(j) processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes. In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from cohort members to access and link their routine health records to their survey data, and to the onward sharing of this linked data in pseudonymised form (via a secure setting with appropriate safeguards). Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). Any previously deposited pseudonymised survey data for a study member and confidential data from the address database are retained unless the study member specifically asks CLS not to, in which cases this data is securely deleted. If the participant has died no contact will be made and the study will be updated to reflect this. In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from the Confidentiality Advisory Group to access this data without consent. CLS has also received Research Ethical Committee (REC) approval for tracing participants. For the NCDS Age 62 survey, CLS have contracted an external supplier NatCen Social Research (the trading name of the National Centre for Social Research) to carry out the individual study members' interviews. NatCen have been commissioned to run interviews with study members for the Age 62 Survey. In addition they will conduct a number of pilot studies in the run-up to the launch of the main survey. NatCen have also contracted an additional Data Processor, Kantar Public, to assist with these tasks. The funding is provided by the Economic and Social Research Council. The age 62 survey is also funded by the Medical Research Council (MRC), the Department for Work and Pensions (DWP) and the U.S National Institute of Health. Funding is in place till 31st May 2025 but is expected to continue beyond this. CLS will use Copyprint to distribute annual mailings to all participants. This exercise serves as an additional method of maintaining contact with as many participants between Age surveys. National Centre for Social Research (NatCen) and Kantar Public are processors acting under the instruction of UCL. NatCen has been contracted to conduct the current Age 62 Survey. NatCen has in turn sub-contracted some of the data collection to Kantar Public. NatCen and Kantar are provided with study member contact details in order to invite participants to take part in the survey. This includes data which has been supplied by NHS England for updated contact information. All processors (mentioned in this application) will have access to participant demographic information and contact details in order to carry out these processes. This includes data which has been supplied by NHS Digital for updated contact information. Amazon Web Services provides cloud hosting services to UCL and will store the data as contracted by UCL. The GDPR legal bases for processing the data held under this Agreement are Article 6(1)(e) - (processing is necessary for the performance of a task in the public interest or in the exercise of official authority vested in the controller) and Article 9(2)(j) VIRTUS Data Centre provides offsite back-up services but does not process the data. (processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes). All those accessing the data supplied by NHS England are substantive employees of University College London or employees of subcontractor organisations (NatCen /Kantar) carrying out work on behalf of UCL. In advance of each sweep of data collection pilot studies are conducted with members of the public of a similar age to study participants. The pilot studies test the feasibility and acceptability of all aspects of the forthcoming survey. Pilot participants are asked to provide feedback on their experience of taking part which is then used to help make decisions about protocols for the survey. In 2019, a series of in-depth interviews and focus groups were conducted with 40 NCDS participants which focused on experiences of prior participation and views on how participants would like to participate in the future. The findings from this research have been and will continue to be used to shape future decisions about the design of NCDS.

Processing activities

This Data Sharing Agreement permits the retention of the data provided under previous iterations of this Agreement. No new data flows between NHS Digital and University College London (UCL) will take place under this Agreement. The following describes the processing activities which took place under previous versions of this Agreement. The CLS at UCL will transfer data to NHS England. The data will consist of identifying details (specifically NHS Number, Date of Birth, full name, Last Known Address, Postcode, Sex and a unique person ID) for the cohort to be linked with NHS England data. NHS address tracing and matching variables: The file supplied will only contain eligible study members who have participated in at least one wave of NCDS. It will not include study members known to have died or to have withdrawn from the study. NHS address tracing. CLS wish to use the patient status and tracking products which uses NHS registration data to trace as many NCDS study members as possible prior to CLS's next survey age 62, either by finding new address details or verifying existing address details for the cohort. NHS England data will provide the relevant records from the Demographics dataset to UCL. The data will contain directly identifying data items including Names, NHS Number, Date of Birth, Address, Postcode, Gender which are required to facilitate contact with participants. CLS will supply NHS Digital with a file with study members to match to the NHS data. The file supplied will only contain eligible study members who have participated in at least one wave of NCDS. It will not include study members known to have died or to have withdrawn from the study. The file will contain the following data items: The data will also contain: [1 paragraph unchanged] - First name - Last name - Middle name (where available), - Date of birth - Sex - Last known address, and postcode - NHS Number NHS Digital would supply the following details to CLS: - CLS identifier - Latest surname - Latest forename - Latest middle name (where available), - Date of birth - Gender - Latest address and postcode [2 paragraphs unchanged] - NHS Number. - Reason for removal date In addition to the receipt of any 'new' matched address information for the study members, NHS Digital will add an additional variable that describes the outcome of the matching process to the data that is returned to CLS – that is, this additional variable will allocate each study member to one of the following four categories: - Reason for removal • new/different address found, The variables requested are required for validation (verify participants' details in the event of matching errors). The 'Reason for removal date' is used to compare the address confirmation data CLS holds on their database. If CLS hold an address which has been confirmed more recently than the ‘reason for removal date’ they receive from NHS England, they will retain the address in their database but if the ‘reason for removal date’ from NHS England is later than the address confirmation date they hold then they will update their records. • existing address confirmed, CLS require identifiers in the circumstance that any discrepancies arise. This is because there are instances where CLS receive identifying details that do not accurately match the cohort member. Using the identifying details CLS will be able to assess whether the details they hold correctly associate with the participant. For example, CLS have had instances where the names they hold and NHS England hold match but the Date of Birth does not match and, in this situation, they would use NHS Number and full name to determine whether it is the correct participant. • no match found, The data will be stored on servers at UCL. • participant has died. UCL uses offsite back-up services provided by VIRTUS Data Centres. If the above is not possible CLS would ask for Match rank and to be provided with the algorithm with which matching was carried out. UCL stores data on the Cloud provided by Amazon Web Services. The data file supplied from NHS Digital, will be processed within CLS and entered into CLS’s secure confidential address database i.e. CLS will load more recent addresses into the database. CLS will use Copyprint to send correspondence to participants inviting them to re-engage with the study. Furthermore, addresses will be used by Natcen and Kantar Public to invite study members to take part in the current survey and future surveys. All NCDS study members contact information is held in secure confidential address databases. The data will be accessed by authorised personnel via remote access. Study members newly traced would be written to and invited to re-engage with the study. Any newly traced study members who on being contacted were to indicate that they no longer wish to participate in the study would be recorded as a 'permanent refusal' on the CLS database and not approached again. The data file supplied by NHS England will be processed within CLS and entered into CLS’s secure confidential address database. The data will remain in the DSH at all times. Access is restricted to employees or agents of UCL, NatCen and Kantar. All those accessing the data supplied by NHS Digital are substantive employees of University College London or employees of subcontractor organisations carrying out work on behalf of UCL. CLS have identified the scenarios where NHS Digital data will be processed by CLS and its Data Processors. Addresses will be used by Natcen and Kantar Public to invite study members to take part in the current survey and future surveys. The data file supplied from NHS Digital, will be reviewed by CLS. Where addresses supplied by NHS Digital are new or more recent than the address currently held on the CLS confidential database the new addresses will be uploaded. No other data will be linked to the NHS England data received. CLS will write to all newly traced cohort members at the addresses that are supplied by NHS Digital – and will ask them to confirm their address by return of a reply slip, telephone, email or via our website. CLS will use Copyprint to send correspondence on behalf of CLS. For this purpose CLS will send names and addresses to Copyprint. All personnel accessing the data have been appropriately trained in data protection and confidentiality. If cohort members confirm their address this will be recorded on the CLS database as a confirmed address. If the letter is ‘returned to sender’ this will be also be recorded on the CLS database. There will also be cases where no confirmation is received and their letter is not returned to sender. Staff using the DSH complete annual training and regularly review data access arrangements ensuring data are only limited to those authorised to access it. Personnel are prohibited from downloading or copying data to local devices. Before commencement of fieldwork for the Age 62 Survey – a ‘sample file’ will be sent to NatCen which will include the names and addresses of all cohort members to be invited to participate in the forthcoming survey. The data will not leave the UK at any time. The sample file will include names and addresses for all study members with a confirmed address AND those addresses supplied by NHS Digital which were neither confirmed nor returned to sender. In some occasions addresses with a 'returned to sender flag will also be sent to NatCen depending on cohort member previous participation. The data will not be linked with any other data. However, it will be compared with existing NCDS data. NatCen will send a letter to all study members on behalf of CLS, which will invite them to participate in the forthcoming survey and will let study members know that an interviewer from NatCen or from Kantar Public will be making contact with them soon. If cohort members confirm their address this will be recorded on the CLS database as a confirmed address. If the letter is ‘returned to sender’ this will also be recorded on the CLS database. There will also be cases where no confirmation is received and their letter is not returned to sender. Before the commencement of fieldwork for the Age 62 Survey – a ‘sample file’ will be sent to NatCen which will allocate half of the study members to be contacted and interviewed by Kantar Public interviewers. NatCen will send include the names and addresses of these cases to Kantar Public – in order that they can allocate study all cohort members to their interviewers. be invited to participate in the forthcoming survey. NatCen interviewers and Kantar Public interviewers will both gain access to the names and addresses via NatCen systems. Kantar Public interviewers will access NatCen systems via a Virtual Machine Network (which is why there is no Storage Location stated for Kantar in this application). The sample file will include names and addresses for all study members with a confirmed address AND those addresses supplied by NHS England which were neither confirmed nor returned to sender. On some occasions, addresses with a 'return to sender’ flag will also be sent to NatCen depending on the cohort member's previous participation. At the end of each interview – names, addresses and other contact details will be confirmed or updated on NatCen systems prior to being returned to CLS. All personal information will then be destroyed by NatCen on completion of their contract. Kantar Public do not hold any data on their own systems. Access to NHS data by Kantar Public is strictly through a Virtual Machine Network used to look up participant data. It is these obligations that define both NatCen and Kantar Public as Data Processors as they will be processing NHS Digital data without CLS replacing the information on their database using details confirmed by the data subject directly. All organisations party to this agreement must comply with the Data Sharing Framework Contract requirements, including those regarding the use (and purposes of that use) by “Personnel” (as defined within the Data Sharing Framework Contract ie: employees, agents and contractors of the Data Recipient who may have access to that data).

Expected output

NCDS is a multidisciplinary cohort study of all babies born in Great Britain in a single week in 1958. The initial birth survey was conducted by midwives in hospitals across Great Britain, comprising a remarkable 98.1% of the target population. Participants have subsequently been followed up at 7, 11, 16, 23, 33, 42, 44/5 (a dedicated biomedical sweep), 46, 50 and 55 years of age. The initial sample of 17,415 individuals was augmented during childhood by immigrants into Great Britain, with a resulting total sample of 18,558. The addresses supplied by NHS England under this agreement will help to boost the sample size and to increase the data collection at future sweeps. The output will be the participation in the survey, for those participants who would not otherwise have participated in the data collection. As a result of the previous list clean, CLS received new contact details for 1,167 participants which have been used to send mailings and invite participants to take part in the current NCDS Age 62 Survey. Following the new list clean CLS will use newly obtained addresses to send future mailings and invitations to future surveys With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build. The main outcome of the study is the next sweep, Age 62 currently underway and scheduled to complete in 2023. This will be a fully documented, anonymised research dataset which will be archived with the UK Data Service to provide a strategically important resource for UK Social Science, including researchers in health and social care. For clarity, the data stored on UK Data Service does not include the NHS England data this Agreement but responses from participants of the study. With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high-quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build. [6 paragraphs unchanged] The data collected will be documented, aggregated in line with the HES Analysis Guide, and archived with the UK Data Service in early 2023 to provide a strategically important resource for UK Social Science, including researchers in health and social care. CLS will produce a range of research outputs based on the NCDS Age 62 Survey, which CLS actively disseminate to participants, policy and practice stakeholders, and the wider scientific community. CLS also promote the data resources themselves to researchers across the public, private and third sectors, in the UK and globally. CLS offers support and advice to external researchers using NCDS data and promotes a selection of their work via CLS’s communication channels. Data and research outputs from the NCDS Age 62 Survey will be disseminated through: Outputs of the list clean : • Scientific journals and pre-prints These addresses obtained from NHS Digital will be used to maintain contact with study members e.g. to send them a special birthday mailing for their birthday and then later to invite them to take part in the Age 62 survey. As a result of the previous list clean - CLS was able to update its database with new contact details for 1705 participants who will receive the birthday mailing in March 2019. They will subsequently be invited to participate in the Age 62 Survey, (unless they withdraw from the study). • CLS working paper series • Free-to-attend training workshops and webinars to support researchers across all sectors and disciplines who are interested in using the data • Free-to-attend in-person and online research seminars open to the public • Co-hosted events or briefings for government, parliamentary or third-sector stakeholders • Digital communications channels, including social media, university websites, podcasts and video • Public reports, particularly when in collaboration with third-sector partners • Direct bilateral engagement with government department partners • Industry newsletters • Briefing documents provided to government department partners, third-sector organisations and other policy and practice stakeholders • Press/media engagement • Participant newsletters

Expected measurable benefits

The central aim of the Age 62 Survey is to enable new research that will inform key public health concerns. The NCDS cohort is now transitioning between midlife and early older age, a critical time when we hypothesise that biological ageing in key systems (e.g., cardiovascular, metabolic, immunity) start to accelerate, and a series of health conditions that have a profound influence on well-being first become clinically manifest. CLS plans to uncover life course and inter-generational factors which contribute to healthy ageing among this generation, and thus to inform the development of preventative health policies across the whole of life that will expand healthy life expectancy, and reduce the burden of ill health and disease at older ages. CLS conceptualises healthy ageing within a life course framework in which we investigate the lifetime socioeconomic, biological, and psychological determinants of health outcomes at age 62, and their contribution to transitions in health and functional outcomes measured objectively from midlife (44/45) to early older age (62). CLS's approach comprises multiple dimensions of health— cardiovascular/metabolic, cognitive, and physical health—and also flexibly incorporates the nature of associations between lifetime determinants and subsequent ageing outcomes, for example allowing for exposures to operate during critical or sensitive periods, or cumulatively across life. Crucially, this framework enables the examination of the interrelationships among these domains of healthy ageing, and the extent to which they have common or separate aetiologies—as is highlighted in the specific examples we set out below. Such a framework also encompasses the mechanisms through which such exposures operate (mediation), as well as whether the adverse effects of exposures on midlife health risk can be modified by other socioeconomic, biological, or psychological factors. One particularly relevant example of effect modification within this framework is reversibility: whether the risk of unhealthy ageing due to exposures in earlier life stages can be reversed or ameliorated in later life, for example through changes to health-related behaviours, or other policy modifiable interventions. Although existing life course health research has largely focused on identifying the early life risk factors for subsequent health, understanding whether such effects can be reversed informs the development of lifetime preventative health policies, and provides valuable information about which stages in the life course remediation of key risks for unhealthy ageing are possible. Compared with alternative approaches – typically based on cross-sectional, or more short-term longitudinal data—which focus solely on adult prevention or remediation, this approach greatly expands the timeframe for intervention, and enables the relative costs and benefits of prevention measures at different life stages to be assessed. The continuing success of the study will be underpinned by CLS maintaining an up to date contact details database for its participants. Submitting the cohort for up-to-date contact details and being able to keep the information for future sweeps, will allow the researchers to re-contact the participants who CLS have lost touch with and give them the opportunity to re-engage or clearly state that they wish to withdraw. It will also ensure that literature goes to the correct name and address and reduces the risk of correspondence being sent to deceased participants and causing potential distress to live relatives. The information collected during the Age 62 Survey and in future sweeps may enable researchers to uncover life course and inter-generational factors which contribute to healthy ageing among this generation, and thus to inform the development of preventative health policies across the whole of life that will expand healthy life expectancy, and reduce the burden of ill-health and disease at older ages. The Age 62 Survey will enable CLS to capture change between age 44/5 and 60, an important period when detrimental changes to underlying markers of health typically occur, and inequalities are magnified. For example, age-related increases in blood pressure (BP) and changes to lipid concentrations have been shown to occur between age 40 to 60, a period when significant functional decline is also expected. Cognitive function has been shown to decline at least as early as 45 years, and this has predictive capacity for later mild cognitive impairment, dementia, and mortality risk. Such changes are also increasingly likely to become clinically manifest around this time, with as many as 85% of Britons having at least one clinical disorder at age 60-64. The Age 62 Survey will also provides valuable baseline data against which future ageing can be quantified. The data collected will be used widely by scientists worldwide to enable the testing of novel hypotheses, and while these cannot be exhaustively described here (indeed, many are as yet unknown), we highlight the distinct potential of this endeavour in four domains, namely cardiometabolic health, physical function, cognitive function, and biological ageing. Cardiometabolic health: Cardiovascular disease (CVD) rates have fallen in recent years, but it remains one of the major causes of death, disability and health care cost. As well as being an important disorder in its own right, CVD also has a detrimental impact on other key health domains, including physical function, and cognition and biological ageing. The obesity epidemic has resulted in escalating rates of diabetes, and threatens to reverse favourable trends in CVD incidence. CVD, obesity and diabetes show clear socioeconomic gradients and are major contributors to health inequalities in UK. Whilst the prevalence of diagnosed CVD before age 60 years is <5%, evidence of subclinical myocardial damage (e.g., elevated levels of cardiac troponin, (cTn)) may be present in >60% of asymptomatic individuals over 60 years of age. Moreover, adverse CVD risk factors (high BP, dyslipidemia, dysglycemia) are common in this age group. By age 60, almost half of the UK population has a BP that is classified as hypertensive; 60-80% have total cholesterol >5mmol/L and in the 50-59 age group ~19% have diabetes. CLS will be measuring a series of cardiometabolic-related outcomes at age 60, comprising repeated measures of those first assessed at age 44/45 (BP, pulse, total and high density lipoprotein cholesterol, glycosylated haemoglobin, and inflammation using C-reactive protein (CRP), and new measures which together include, myocardial damage (by cardiac troponin-I (cTn), cardiac hemodynamic load, CVD and heart failure risk (by NT pro-BNP). Height and weight will be measured directly using standardised protocols and bioimpedance used to estimate fat and lean mass. Measurements will also include sitting and standing BP (postural hypotension). Blood lipids will be assessed using a validated low cost NMR metabolomics assay which additionally provides information on over 200 blood metabolites. These metabolites provide extensive insight into systemic metabolism and have been shown to add to risk prediction of future total mortality, CVD and diabetes over and above conventional risk factors. Diabetes will be diagnosed on the basis of self-report and HbA1c. cTn, CRP and NT pro-BNP will be measured using validated high sensitivity assays. Following carefully devised ethical protocols, feedback will be provided to participants and to their GPs, subject to consent. There is evidence that factors in childhood, such as socioeconomic adversity, overweight, low cognition and childhood abuse may be associated with elevated adult CVD rates. It may also be the case that that exposure to infectious disease in utero and childhood may increase adult CVD risk. Infectious challenges are particularly common in children, elicit an inflammatory response that is central to the pathogenesis of atherosclerosis and cause endothelial dysfunction. In the absence of direct measurement of infectious disease in either utero or in childhood, investigators have used proxies, such as number of siblings or retrospective serological evidence of prior exposure to specific pathogens. In the only prospective evidence of which we are aware, childhood illness of sufficient severity to warrant hospitalisation was associated with markers of atherosclerosis. However, the roles of less severe infection during childhood which do not require hospitalisation and prevail today (influenza, chest infections, common cold), in addition to exposure to infections in utero, are unknown. NCDS is uniquely suited to address these uncertainties: it contains individual level data on maternal influenza during pregnancy, and medical history data collected at 7, 11 and 16 years of age with reports of infectious diseases from multiple sources (parent, health visitor, and study doctor). Moreover, owing to the UK 1957 Asian flu pandemic, cohort members have unusually high exposure to maternal influenza the severity of which peaked when they were between 17 and 23 weeks in gestation. These data will be used to test the hypothesis that in utero exposure to influenza leads to subclinical cardiometabolic disease at age 62. In utero exposure will be measured by a novel combination of two sources of exposure: individual-level data on severity, frequency, and system affected plus local authority variation in maternal exposure, the latter providing a potential instrument for identification of causal effects of exposure. While the childhood factors that increase CVD risk in midlife are becoming better understood, there is less evidence on whether the risk of unhealthy ageing due to exposures in earlier life stages can be reversed or ameliorated in midlife, for example via the changes to health behaviours. The existence of diverse life course trajectories of physical activity in NCDS, and multiple observations in midlife will allow us to examine the hypothesis that greater exercise participation in midlife, which exerts a range of beneficial effects including anti-inflammatory actions, may ameliorate, or partially reverse these risks. Preliminary analyses suggest that NCDS contains both sufficient variation in physical activity across adult life, and sufficient sample sizes for this hypothesis to be robustly tested. Another often overlooked issue which NCDS would address is that, in order for prevention to be effective, at risk individuals must be identified and effectively treated. Levels of undiagnosed and inadequately treated CVD risk factors (e.g. hypertension, dyslipidemia and diabetes) remain worryingly high in UK. For example, in the Health Survey for England more than 33% of individuals with hypertension were undiagnosed, and of those diagnosed, only 53% were adequately treated; less than half of eligible individuals took statins, and there is a similar lack of awareness and poor control of diabetes. Understanding this issue, in addition to new therapies, is a major need in CVD research. Previous cross-sectional studies have suggested that adult personality characteristics such as lower conscientiousness are associated with poorer CVDrelated treatment adherence. Such studies do not, however, elucidate whether early life personality characteristics have long-standing implications for treatment outcomes, and the reported associations may be confounded by preceding cognitive function or health. NCDS will be used to examine the hypothesis that higher childhood cognitive function and other traits such as conscientiousness, and self-regulation are associated with improved control of cardiometabolic risk factors in adulthood—as would be anticipated given the apparent long term effects of these factors on other related outcomes. Since many of these characteristics, even personality traits in childhood, are increasingly understood to be modifiable, such evidence would add to the long-standing public health and wider societal benefits of improving cognitive and socioemotional developmental outcomes among children. Physical function: Physical function or capability—the capacity to undertake the physical tasks of daily living—is a recognised component of most definitions of healthy ageing, with impaired function ultimately resulting in mobility disability and loss of independence. Mobility disability is highly prevalent, affecting 6.5 million UK adults in 2011/12, and has costly implications for public health and social care. Understanding the causes of low physical function in older age thus may lead to interventions which could prevent or delay the onset of mobility disability. Maintaining or improving physical function may also benefit other outcomes, since objective measures of low physical function such as weak hand-grip strength are associated with marked increases in health service use, premature mortality and other health outcomes. Due to these comparatively strong and consistent relationships, physical function measures are considered important biomarkers of ageing. For the first time in NCDS, we will objectively measure adult physical function at age 62. Multiple measures will be used, including grip strength, standing balance time and walking speed. Obtaining different measures is important as they may capture different functional domains: despite drawing on shared physiological processes, the measures are typically weakly mutually correlated in early old age, and show independent associations with health outcomes such as mortality. Investigation of the lifetime determinants of these measures may therefore result in the identification of multiple potential targets for public health intervention (both in terms of type and timing). Measuring physical function in NCDS will also enable the identification of lifetime determinants of specific geriatric phenotypes of public health significance. Cognitive function and decline: A central concern in health and social care provision is the impact of cognitive impairment and dementia. Due to population ageing, the prevalence of cognitive impairment and dementia may increase, despite reductions in incidence. With drug treatments presently ineffective, identification of the modifiable drivers over the life course of both normal and accelerated cognitive decline is required, which could, via appropriate policy-based intervention, delay the onset of cognitive impairment and dementia. We will collect cognitive function data in the Age 62 Survey, repeating measures previously obtained at age 50 of memory (immediate and delayed word-list recall) verbal fluency (animal naming) and attention/mental speed (letter cancellation). Collecting these cognitive data will be valuable because most evidence of the determinants of normal and accelerated cognitive decline in midlife is based on studies initiated in older adults. We will test the hypothesis that adverse cardiometabolic risk factors are related to lower cognitive functioning and greater cognitive decline in midlife, independently of childhood cognitive ability, and we will also examine the causal pathways underpinning these associations, including both potential social (health behaviours, medication use) and biological mediators (including components of the human metabolome linked to mild-cognitive impairment). NCDS is unique in having detailed continuous work histories collected from age 16 to 60, and capturing working status and retirement expectations will be an important feature of the data collection planned at age 60. At the age of 55, the large majority of the cohort (82% of men and 73% of women) envisaged that they would be working beyond the age of 60 (and 51% of men and 42% expected to work beyond the state pension age of 66). However, by the age of 60 we anticipate a significant proportion will have left the labour market, many for health-related reasons, while many will no longer be working in their main occupation. This cohort is especially well-placed to address the complex interrelationships between cognition and work including the hypothesis that cognitive trajectories across life affect labour market status and expectations, and also, conversely, that patterns of work across the life course (continuous labour market attachment, hours, and quality of work) affects cognitive function at age 62. While previous studies using cohorts initiated in adulthood have suggested that a number of work-related characteristics may benefit adult cognition, including being continuously employed, participating in mentally demanding jobs, and working a moderate number of hours per week, we will be able to advance this research area in several directions. First, we will be able to account for the fact that the individuals who remain in continuous employment are likely to be a positively selected sample, i.e. for the “healthy worker effect”. Second, we will strengthen causal inference by using random variation in unemployment rates across local labour markets and over time as an instrument for employment status. Third, the availability of unique information on reasons for job changes (e.g. redundancy or firm closure) will enable us to examine the impact of job loss due to exogenous reasons on cognitive decline between ages 50 and 60. Fourth, we will investigate whether the quantity (e.g. hours) and the quality (e.g. autonomy) of work impacts on subsequent cognitive function. The collection of cognitive measures in NCDS also enables cross-cohort comparative work with the 1946 birth cohort. For example, to test the hypothesis that increases in women’s education attainment (due to increases in compulsory schooling) and labour market participation would lead to higher cognition at age 62, and slower rates of cognitive decline in NCDS. Such data could also be used to examine whether these processes differ by socioeconomic status, or if socioeconomic inequalities in cognition and its decline differ in the NCDS compared with the 1946 birth cohort. Benefits of the list cleaning: The ongoing success of NCDS is dependent on maintaining contact with the maximum number of study members. Submitting the cohort for list cleaning will allow the researchers to recontact participants where contact has been lost in order to give them the opportunity to re-engage with the study (or state that they wish to withdraw). This will ensure that the sample size for the Age 62 Survey (and also future surveys) is maximised. It will also minimise the risk of literature going to the incorrect address, and contact being made with participants who have died.

Benefits reported

Findings from NCDS have repeatedly impacted on policy. Amongst its earliest findings was the discovery that maternal smoking in pregnancy was associated with higher rates of spontaneous abortion, lower birthweight in viable offspring, and reduced cognitive function in childhood which were not, as was suspected, due to confounding by social circumstances. An important part of the study’s history took place in 2002/3—the first and only full adult biomedical at age 44/5. This data collection yielded new insights into the environmental determinants of an array of adult health outcomes, and made a major impact on the understanding of the genetic underpinning of disease through its pioneering role as one of two sets of national ‘healthy’ controls in the Wellcome Trust Case Control Consortium (WTCCC). This data collection has also had a major impact through analyses based on NCDS’s life course data, demonstrating, for example, the life course continuity of psychological distress and its role as a determinant of future social circumstances; the influence of obesity across life on glucose metabolism, diabetes, and raised BP; and the link between lower pre-adult cognitive function and CVD risk factors and widespread pain; and a growing understanding of the pernicious long term effects of early life adversities such as poor social circumstances, experiences of neglect, abuse, and bullying on later impaired pulmonary function, indicators of cumulative physiological damage, inflammation, obesity, and cortisol patterns. Findings on Vitamin D deficiency in midlife led to the initiation of supplementation trials. NCDS has a high scientific output to date, as evidenced by the large number of publications and citations across a wide range of disciplines. In total over 1600 research publications have been produced using NCDS data since 2008 - of which a very significant proportion are focused on aspects of health. Below are some examples of existing publications using NCDS data benefiting public health: In the NCDS 55 Survey which was conducted in 2013, UCL CLS achieved a large number of interviews with participants who had been newly traced to an address supplied by NHS England. The addresses obtained in previous versions of this agreement were also very useful to invite study members (NCDS age 44) to take part and re-engage with the studies. Using addresses provided by the NHS England helped CLS get in touch with those cohort members who would otherwise not be able to take part in a new survey. ABO-ZAID, G, SHARPE, R.A., FLEMING, L.E., DEPLEDGE, M and OSBORNE, N.J.. (2018) Association of Infant Eczema with Childhood and Adult Asthma: Analysis of Data from the 1958 Birth Cohort Study. International Journal of Environmental Research and Public Health, 15(7), 1415. The NCDS data is now available for researchers to access via the UK Data Service, providing an important resource for UK Social Science, including researchers in health and social care. https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=5560 IMPACT: Research using NCDS Cohort Study data has contributed to better understanding the relationship between early life eczema and asthma later in life. Detailed information about the study can be found here: https://www.mdpi.com/1660-4601/15/7/1415 BANN, D, JOHNSON, W, LI, L, KUH, D and HARDY, R. (2018) Socioeconomic inequalities in childhood and adolescent body-mass index, weight, and height from 1953 to 2015: an analysis of four longitudinal, observational, British birth cohort studies. Lancet Public Health, 3(4), e194-e203. IMPACT: Research using NCDS Cohort Study data has enabled a long-run investigation of socioeconomic inequalities in BMI, and to more recent data than previously available. Detailed information about the study can be found here: https://www.sciencedirect.com/science/article/pii/S2468266718300458?via%3Dihub BEAUMONT, R.N, WARRINGTON, N.M, CAVADINO, A, TYRRELL, J, NODZENSKI, M, HORIKOSHI, M, GELLER, F, MYHRE, R, RICHMOND, R.C, PATERNOSTER, L, BRADFIELD, J.P, KREINER-MØLLER, E, HUIKARI, V, METRUSTRY, S, LUNETTA, K.L, PAINTER, J.N, HOTTENGA, J-J, ALLARD, C, BARTON, S.J, ESPINOSA, A, MARSH, J.A, POTTER, C, ZHANG, G, ANG, W, BERRY, D.J, BOUCHARD, L, DAS, S, EARLY GROWTH GENETICS (EGG) CONSORTIUM, HAKONARSON, H, HEIKKINEN, J, HELGELAND, Ø, HOCHER, B, HOFMAN, A, INSKIP, H.M, JONES, S.E, KOGEVINAS, M, LIND, P.A, MARULLO, L, MEDLAND, S.E, MURRAY, A, MURRAY, J.C, NJØLSTAD, P.R, NOHR, E.A, REICHETZEDER, C, RING, S.M, RUTH, K.S, SANTA-MARINA, L, SCHOLTENS, D.M, SEBERT, S, SENGPIEL, V, TUKE, M.A, VAUDEL, M, WEEDON, M.N, WILLEMSEN, G, WOOD, A.R, YAGHOOTKAR, H, MUGLIA, L.J, BARTELS, M, RELTON, C.L, PENNELL, C.E, CHATZI, L, ESTIVILL, X, HOLLOWAY, J.W, BOOMSMA, D.I, MONTGOMERY, G.W, MURABITO, J.M, SPECTOR, T.D, POWER, C, JÄRVELIN, M-R, BISGAARD, H, GRANT, S.F, SØRENSEN, T.I, JADDOE, V.W, JACOBSSON, B, MELBYE, M, MCCARTHY, M.I, HATTERSLEY, A.T, HAYES, M.G, FRAYLING, T.M, HIVERT, M-F, FELIX, J.F, HYPPÖNEN, E, LOWE, W.L, EVANS, D.M, LAWLOR, D.A, FEENSTRA, B and FREATHY, R.M. (2018) Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics. Human Molecular Genetics, 27(4), 742-756. IMPACT: Research using NCDS Cohort Study data has contributed to better understanding of the role of maternal genetic variation on fetal birth weight. Detailed information about the study can be found here: https://academic.oup.com/hmg/article/27/4/742/4788598 • Power, C., & Matthews, S. (1997). Origins of health inequalities in a national population sample. The Lancet, 350(9091), 1584-1589. • Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007; 85 (3):860-8. • Strachan, D.P., 2000. Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax, 55 (Suppl 1), p.S2. • Clark C, Rodgers B, Caldwell T, Power C, Stansfeld S. Childhood and adulthood psychological ill health as predictors of midlife affective and anxiety disorders: the 1958 British Birth Cohort. Arch Gen Psychiatry. 2007; 64 (6):668-78. • Orfei L, Strachan DP, Rudnicka AR, Wadsworth M. Early influences on adult lung function in two national British cohorts. Arch Dis Child. 2008; 93 (7):570-4. • Johnson W, Li L, Kuh D, Hardy R. How Has the Age-Related Process of Overweight or Obesity Development Changed over Time? Co-ordinated Analyses of Individual Participant Data from Five United Kingdom Birth Cohorts. PLoS Med. 2015; 12 (5):e1001828.

Objective for processing

University College London (UCL) requires access to NHS England data for the purpose of the National Childhood Development Study (NCDS). The study follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on.

Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of the enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50 and 55. The most recent survey commenced in 2020 when participants were aged 62. However, it was paused due to the pandemic, but this is now underway once again with an estimated end date of June 2023.

UCL's Centre for Longitudinal Studies (CLS) loses touch with participants when they move home between surveys. CLS therefore requires the latest addresses for study members so that they can be contacted and invited to continue participating in the study. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives. Failure to make contact is the most significant cause of non-participation in the study. Evidence from prior surveys confirms that when contact is re-established many participants are keen to re-engage with the study and continue to participate. The receipt of up-to-date addresses for study members helps CLS maintain contact with participants which is crucial to the ongoing success of the study.

Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). CLS will not seek to trace those participants which are flagged as permanent refusals, those cases will be removed from the matching file sent to NHS England. If a participant has died, the database will be updated to reflect this and ensure no subsequent attempts to contact will be made.

Tracing via NHS England is just one of the steps that CLS take to maintain contact with participants. In addition, CLS sends an annual mailing to participants which includes a reply slip which participants are asked to return to either confirm the contact details held or to provide updates. CLS also provides participants with ‘change of address’ cards which they are asked to return if they move. CLS also collects contact details for ‘stable contacts’ who can be contacted in the event that contact is lost with the cohort member.

The following NHS England data will be accessed:

• Demographics data - necessary so UCL can maintain contact with as large a number of study members as possible. CLS require updated addresses for study members.

The level of data will be identifiable – necessary to validate the participant's details and cross-check against the CLS database.

The data will be minimised as follows.

• Limited to data for approximately 13,000 participants of the NCDS study

UCL is the controller as the organisation responsible for ensuring that the data will only be processed for the purpose described above.

The lawful basis for processing personal data under the UK GDPR is Article 6(1)(e) - processing is necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller;

The lawful basis for processing special category data under UK GDPR is Article 9(2)(j) processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes. In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from cohort members to access and link their routine health records to their survey data, and to the onward sharing of this linked data in pseudonymised form (via a secure setting with appropriate safeguards).

In addition, for ethical reasons and under the Common Law Duty of Confidentiality, UCL sought permission from the Confidentiality Advisory Group to access this data without consent. CLS has also received Research Ethical Committee (REC) approval for tracing participants.

The funding is provided by the Economic and Social Research Council. The age 62 survey is also funded by the Medical Research Council (MRC), the Department for Work and Pensions (DWP) and the U.S National Institute of Health. Funding is in place till 31st May 2025 but is expected to continue beyond this.

National Centre for Social Research (NatCen) and Kantar Public are processors acting under the instruction of UCL. NatCen has been contracted to conduct the current Age 62 Survey. NatCen has in turn sub-contracted some of the data collection to Kantar Public. NatCen and Kantar are provided with study member contact details in order to invite participants to take part in the survey. This includes data which has been supplied by NHS England for updated contact information.

Amazon Web Services provides cloud hosting services to UCL and will store the data as contracted by UCL.

VIRTUS Data Centre provides offsite back-up services but does not process the data.

All those accessing the data supplied by NHS England are substantive employees of University College London or employees of subcontractor organisations (NatCen /Kantar) carrying out work on behalf of UCL.

In advance of each sweep of data collection pilot studies are conducted with members of the public of a similar age to study participants. The pilot studies test the feasibility and acceptability of all aspects of the forthcoming survey. Pilot participants are asked to provide feedback on their experience of taking part which is then used to help make decisions about protocols for the survey. In 2019, a series of in-depth interviews and focus groups were conducted with 40 NCDS participants which focused on experiences of prior participation and views on how participants would like to participate in the future. The findings from this research have been and will continue to be used to shape future decisions about the design of NCDS.

Expected output

The addresses supplied by NHS England under this agreement will help to boost the sample size and to increase the data collection at future sweeps. The output will be the participation in the survey, for those participants who would not otherwise have participated in the data collection. As a result of the previous list clean, CLS received new contact details for 1,167 participants which have been used to send mailings and invite participants to take part in the current NCDS Age 62 Survey. Following the new list clean CLS will use newly obtained addresses to send future mailings and invitations to future surveys

The main outcome of the study is the next sweep, Age 62 currently underway and scheduled to complete in 2023. This will be a fully documented, anonymised research dataset which will be archived with the UK Data Service to provide a strategically important resource for UK Social Science, including researchers in health and social care. For clarity, the data stored on UK Data Service does not include the NHS England data this Agreement but responses from participants of the study.

With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high-quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build.

The Age 62 Survey will be comprised of two major components:

1) A core interview which will cover the following topics:

Health, well-being and cognition: physical health, mental health, medical care, health behaviours (e.g. smoking, drinking, diet, exercise), cognitive function.

Finances and employment: work, income, wealth (savings and debts, pensions, & housing), retirement plans & education.

Family, relationships and identity: social networks, relationships with partners, parents, children, friends, neighbourhood, social capital, social and political participation, attitudes and values, and religion.

2) A detailed biomedical assessment including measures of anthropometry, physical functioning, cardiovascular risk factors and a full range of blood tests. The central aim of this biomedical assessment is to enable new research that will inform key public health concerns.

CLS will produce a range of research outputs based on the NCDS Age 62 Survey, which CLS actively disseminate to participants, policy and practice stakeholders, and the wider scientific community. CLS also promote the data resources themselves to researchers across the public, private and third sectors, in the UK and globally. CLS offers support and advice to external researchers using NCDS data and promotes a selection of their work via CLS’s communication channels. Data and research outputs from the NCDS Age 62 Survey will be disseminated through:

• Scientific journals and pre-prints

• CLS working paper series

• Free-to-attend training workshops and webinars to support researchers across all sectors and disciplines who are interested in using the data

• Free-to-attend in-person and online research seminars open to the public

• Co-hosted events or briefings for government, parliamentary or third-sector stakeholders

• Digital communications channels, including social media, university websites, podcasts and video

• Public reports, particularly when in collaboration with third-sector partners

• Direct bilateral engagement with government department partners

• Industry newsletters

• Briefing documents provided to government department partners, third-sector organisations and other policy and practice stakeholders

• Press/media engagement

• Participant newsletters

Benefits reported

In the NCDS 55 Survey which was conducted in 2013, UCL CLS achieved a large number of interviews with participants who had been newly traced to an address supplied by NHS England. The addresses obtained in previous versions of this agreement were also very useful to invite study members (NCDS age 44) to take part and re-engage with the studies. Using addresses provided by the NHS England helped CLS get in touch with those cohort members who would otherwise not be able to take part in a new survey.

The NCDS data is now available for researchers to access via the UK Data Service, providing an important resource for UK Social Science, including researchers in health and social care. https://beta.ukdataservice.ac.uk/datacatalogue/studies/study?id=5560

DARS-NIC-137864-T1P9B-v5.4 18 January 2022 to 17 January 2023
Title
MR1450 - National Child Development Study (NCDS)
Commercial
No
Sublicensing
No
Datasets
2
Files released
0

Datasets: Demographics; MRIS - List Cleaning Report

What changed from DARS-NIC-137864-T1P9B-v4.2

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-137864-T1P9B-v4.2
FieldWasBecame
Start date2020-10-192022-01-18
End date2022-01-172023-01-17

Objective for processing

This Data Sharing Agreement permits the retention of the data provided under previous iterations of this Agreement. No new data flows between NHS Digital and University College London (UCL) will take place under this Agreement. The following describes the purposes for which data was supplied under previous versions of this Agreement. [16 paragraphs unchanged] The GDPR legal bases for processing the data held under this Agreement are Article 6(1)(e) - (processing is necessary for the performance of a task in the public interest or in the exercise of official authority vested in the controller) and Article 9(2)(j) (processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes).

Processing activities

This Data Sharing Agreement permits the retention of the data provided under previous iterations of this Agreement. No new data flows between NHS Digital and University College London (UCL) will take place under this Agreement. The following describes the processing activities which took place under previous versions of this Agreement. [43 paragraphs unchanged]

Unchanged: Expected output, Expected measurable benefits, Benefits reported.

Objective for processing

This Data Sharing Agreement permits the retention of the data provided under previous iterations of this Agreement. No new data flows between NHS Digital and University College London (UCL) will take place under this Agreement. The following describes the purposes for which data was supplied under previous versions of this Agreement.

The National Child Development Study (NCDS) is the second of Britain’s world renowned national longitudinal birth cohort studies. It follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on. The study has its origins in the Perinatal Mortality Survey. Sponsored by the National Birthday Trust Fund, this was designed to examine the social and obstetric factors associated with stillbirth and death in early infancy among the children born in Great Britain in that one week. Information was gathered from 17,415 babies.

Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50 and 55. The next NCDS survey will take place in 2020 when study members will be aged 62.

In 1958, when the birth survey was carried out, consent to participate in surveys was gained by respondents agreeing to be interviewed or respondents returning the completed questionnaire to the study team. Involvement in subsequent surveys adopted the same approach. Individuals could withdraw from the study at any time by simply expressing the wish to do so.

In all recent follow-ups the approach to collecting consent has been very similar. During fieldwork, study members were sent an advance letter advising them about the survey. The letter was accompanied by an information leaflet explaining what is involved. Study members had the opportunity to request further information, or to opt out of the survey at this point. They could also seek further information, or refuse further involvement when the interviewer attempted to make an appointment to visit; when the interviewer visited and at any point during the administration of any elements of the surveys.

Of the approximately 17415 individuals that have ever participated in the study there will always be a number of individuals for whom the Centre for Longitudinal Studies (CLS) at University College London will not have a confirmed addresses at the time of carrying out the next survey. For example, In the most recent tracing exercise conducted with NHS Digital - CLS sent just under 3,500 study members for matching. It is estimated that the number of study members which will be sent for matching in the next exercise will be lower than this.

The ongoing success of the study depends on maintaining contact with as large a number of study members as possible. Therefore, CLS are seeking permission to be supplied with updated addresses for these study members whose whereabouts are currently unknown. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives.

Objective:

Each year CLS sends an annual birthday card postal mailing in March to all NCDS participants. CLS asks that participants complete a ‘reply slip’ which is returned to CLS which allows participants to provide CLS with any change in their details e.g. a new email address, phone number, etc. CLS also ask them to return the reply slip even if none of their details have changed i.e. seeking a positive confirmation that that is the address CLS hold for them.

As a result CLS, can maintain the cohorts' latest details on the NCDS database. In the event of the birthday card not reaching the participant it is returned to CLS as a ‘return to sender’. CLS will attempt to trace all these returns – but if CLS cannot locate the participants then they are flagged on the database as a ‘gone-away’. It is these cases that are being sent to NHS Digital for list cleaning as the NHS may potentially hold a more recent address and provide CLS with an opportunity to invite the cohort to re-join the study.

NHS Digital will supply new addresses for untraced study members who can be matched to the NHS Central Registry/Personal Demographics Service (PDS).

CLS require to trace lost study members between now and the Age 62 survey in 2020 which is currently in the planning stage. Any study members successfully traced via this route would be written to and asked to provide updated contact details. They will then subsequently be invited to participate in the NCDS Age 62 survey (unless they withdraw from the study).

All those the researchers would seek to trace have participated in at least one prior sweep of the study and none have ever informed CLS that they no longer wish to participate in the study. The researchers feel that a substantial number of these individuals would be willing to participate in the study if they could be contacted. Previous efforts to re-establish contact for other cohort studies have been very successful using this route. When the cohort are contacted they will be given the opportunity to withdraw.

Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). Any previously deposited pseudonymised survey data for a study member and confidential data from the address database are retained unless the study member specifically asks CLS not to, in which cases this data is securely deleted. If the participant has died no contact will be made and the study will be updated to reflect this.

For the NCDS Age 62 survey, CLS have contracted an external supplier NatCen Social Research (the trading name of the National Centre for Social Research) to carry out the individual study members' interviews. NatCen have been commissioned to run interviews with study members for the Age 62 Survey. In addition they will conduct a number of pilot studies in the run-up to the launch of the main survey. NatCen have also contracted an additional Data Processor, Kantar Public, to assist with these tasks.

CLS will use Copyprint to distribute annual mailings to all participants. This exercise serves as an additional method of maintaining contact with as many participants between Age surveys.

All processors (mentioned in this application) will have access to participant demographic information and contact details in order to carry out these processes. This includes data which has been supplied by NHS Digital for updated contact information.

The GDPR legal bases for processing the data held under this Agreement are Article 6(1)(e) - (processing is necessary for the performance of a task in the public interest or in the exercise of official authority vested in the controller) and Article 9(2)(j)

(processing is necessary for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes).

Expected output

NCDS is a multidisciplinary cohort study of all babies born in Great Britain in a single week in 1958. The initial birth survey was conducted by midwives in hospitals across Great Britain, comprising a remarkable 98.1% of the target population. Participants have subsequently been followed up at 7, 11, 16, 23, 33, 42, 44/5 (a dedicated biomedical sweep), 46, 50 and 55 years of age. The initial sample of 17,415 individuals was augmented during childhood by immigrants into Great Britain, with a resulting total sample of 18,558.

With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build.

The Age 62 Survey will be comprised of two major components:

1) A core interview which will cover the following topics:

Health, well-being and cognition: physical health, mental health, medical care, health behaviours (e.g. smoking, drinking, diet, exercise), cognitive function.

Finances and employment: work, income, wealth (savings and debts, pensions, & housing), retirement plans & education.

Family, relationships and identity: social networks, relationships with partners, parents, children, friends, neighbourhood, social capital, social and political participation, attitudes and values, and religion.

2) A detailed biomedical assessment including measures of anthropometry, physical functioning, cardiovascular risk factors and a full range of blood tests. The central aim of this biomedical assessment is to enable new research that will inform key public health concerns.

The data collected will be documented, aggregated in line with the HES Analysis Guide, and archived with the UK Data Service in early 2023 to provide a strategically important resource for UK Social Science, including researchers in health and social care.

Outputs of the list clean :

These addresses obtained from NHS Digital will be used to maintain contact with study members e.g. to send them a special birthday mailing for their birthday and then later to invite them to take part in the Age 62 survey. As a result of the previous list clean - CLS was able to update its database with new contact details for 1705 participants who will receive the birthday mailing in March 2019. They will subsequently be invited to participate in the Age 62 Survey, (unless they withdraw from the study).

Benefits reported

Findings from NCDS have repeatedly impacted on policy. Amongst its earliest findings was the discovery that maternal smoking in pregnancy was associated with higher rates of spontaneous abortion, lower birthweight in viable offspring, and reduced cognitive function in childhood which were not, as was suspected, due to confounding by social circumstances. An important part of the study’s history took place in 2002/3—the first and only full adult biomedical at age 44/5. This data collection yielded new insights into the environmental determinants of an array of adult health outcomes, and made a major impact on the understanding of the genetic underpinning of disease through its pioneering role as one of two sets of national ‘healthy’ controls in the Wellcome Trust Case Control Consortium (WTCCC). This data collection has also had a major impact through analyses based on NCDS’s life course data, demonstrating, for example, the life course continuity of psychological distress and its role as a determinant of future social circumstances; the influence of obesity across life on glucose metabolism, diabetes, and raised BP; and the link between lower pre-adult cognitive function and CVD risk factors and widespread pain; and a growing understanding of the pernicious long term effects of early life adversities such as poor social circumstances, experiences of neglect, abuse, and bullying on later impaired pulmonary function, indicators of cumulative physiological damage, inflammation, obesity, and cortisol patterns. Findings on Vitamin D deficiency in midlife led to the initiation of supplementation trials. NCDS has a high scientific output to date, as evidenced by the large number of publications and citations across a wide range of disciplines. In total over 1600 research publications have been produced using NCDS data since 2008 - of which a very significant proportion are focused on aspects of health. Below are some examples of existing publications using NCDS data benefiting public health:

ABO-ZAID, G, SHARPE, R.A., FLEMING, L.E., DEPLEDGE, M and OSBORNE, N.J.. (2018) Association of Infant Eczema with Childhood and Adult Asthma: Analysis of Data from the 1958 Birth Cohort Study. International Journal of Environmental Research and Public Health, 15(7), 1415.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding the relationship between early life eczema and asthma later in life.

Detailed information about the study can be found here:

https://www.mdpi.com/1660-4601/15/7/1415

BANN, D, JOHNSON, W, LI, L, KUH, D and HARDY, R. (2018) Socioeconomic inequalities in childhood and adolescent body-mass index, weight, and height from 1953 to 2015: an analysis of four longitudinal, observational, British birth cohort studies. Lancet Public Health, 3(4), e194-e203.

IMPACT: Research using NCDS Cohort Study data has enabled a long-run investigation of socioeconomic inequalities in BMI, and to more recent data than previously available.

Detailed information about the study can be found here:

https://www.sciencedirect.com/science/article/pii/S2468266718300458?via%3Dihub

BEAUMONT, R.N, WARRINGTON, N.M, CAVADINO, A, TYRRELL, J, NODZENSKI, M, HORIKOSHI, M, GELLER, F, MYHRE, R, RICHMOND, R.C, PATERNOSTER, L, BRADFIELD, J.P, KREINER-MØLLER, E, HUIKARI, V, METRUSTRY, S, LUNETTA, K.L, PAINTER, J.N, HOTTENGA, J-J, ALLARD, C, BARTON, S.J, ESPINOSA, A, MARSH, J.A, POTTER, C, ZHANG, G, ANG, W, BERRY, D.J, BOUCHARD, L, DAS, S, EARLY GROWTH GENETICS (EGG) CONSORTIUM, HAKONARSON, H, HEIKKINEN, J, HELGELAND, Ø, HOCHER, B, HOFMAN, A, INSKIP, H.M, JONES, S.E, KOGEVINAS, M, LIND, P.A, MARULLO, L, MEDLAND, S.E, MURRAY, A, MURRAY, J.C, NJØLSTAD, P.R, NOHR, E.A, REICHETZEDER, C, RING, S.M, RUTH, K.S, SANTA-MARINA, L, SCHOLTENS, D.M, SEBERT, S, SENGPIEL, V, TUKE, M.A, VAUDEL, M, WEEDON, M.N, WILLEMSEN, G, WOOD, A.R, YAGHOOTKAR, H, MUGLIA, L.J, BARTELS, M, RELTON, C.L, PENNELL, C.E, CHATZI, L, ESTIVILL, X, HOLLOWAY, J.W, BOOMSMA, D.I, MONTGOMERY, G.W, MURABITO, J.M, SPECTOR, T.D, POWER, C, JÄRVELIN, M-R, BISGAARD, H, GRANT, S.F, SØRENSEN, T.I, JADDOE, V.W, JACOBSSON, B, MELBYE, M, MCCARTHY, M.I, HATTERSLEY, A.T, HAYES, M.G, FRAYLING, T.M, HIVERT, M-F, FELIX, J.F, HYPPÖNEN, E, LOWE, W.L, EVANS, D.M, LAWLOR, D.A, FEENSTRA, B and FREATHY, R.M. (2018) Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics. Human Molecular Genetics, 27(4), 742-756.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding of the role of maternal genetic variation on fetal birth weight.

Detailed information about the study can be found here:

https://academic.oup.com/hmg/article/27/4/742/4788598

• Power, C., & Matthews, S. (1997). Origins of health inequalities in a national population sample. The Lancet, 350(9091), 1584-1589.

• Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007; 85 (3):860-8.

• Strachan, D.P., 2000. Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax, 55 (Suppl 1), p.S2.

• Clark C, Rodgers B, Caldwell T, Power C, Stansfeld S. Childhood and adulthood psychological ill health as predictors of midlife affective and anxiety disorders: the 1958 British Birth Cohort. Arch Gen Psychiatry. 2007; 64 (6):668-78.

• Orfei L, Strachan DP, Rudnicka AR, Wadsworth M. Early influences on adult lung function in two national British cohorts. Arch Dis Child. 2008; 93 (7):570-4.

• Johnson W, Li L, Kuh D, Hardy R. How Has the Age-Related Process of Overweight or Obesity Development Changed over Time? Co-ordinated Analyses of Individual Participant Data from Five United Kingdom Birth Cohorts. PLoS Med. 2015; 12 (5):e1001828.

DARS-NIC-137864-T1P9B-v4.2 19 October 2020 to 17 January 2022
Title
MR1450 - National Child Development Study (NCDS)
Commercial
No
Sublicensing
No
Datasets
2
Files released
5

Datasets: Demographics; MRIS - List Cleaning Report

What changed from DARS-NIC-137864-T1P9B-v3.2

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-137864-T1P9B-v3.2
FieldWasBecame
Start date2020-04-172020-10-19

Unchanged: Objective for processing, Processing activities, Expected output, Expected measurable benefits, Benefits reported.

Objective for processing

The National Child Development Study (NCDS) is the second of Britain’s world renowned national longitudinal birth cohort studies. It follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on. The study has its origins in the Perinatal Mortality Survey. Sponsored by the National Birthday Trust Fund, this was designed to examine the social and obstetric factors associated with stillbirth and death in early infancy among the children born in Great Britain in that one week. Information was gathered from 17,415 babies.

Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50 and 55. The next NCDS survey will take place in 2020 when study members will be aged 62.

In 1958, when the birth survey was carried out, consent to participate in surveys was gained by respondents agreeing to be interviewed or respondents returning the completed questionnaire to the study team. Involvement in subsequent surveys adopted the same approach. Individuals could withdraw from the study at any time by simply expressing the wish to do so.

In all recent follow-ups the approach to collecting consent has been very similar. During fieldwork, study members were sent an advance letter advising them about the survey. The letter was accompanied by an information leaflet explaining what is involved. Study members had the opportunity to request further information, or to opt out of the survey at this point. They could also seek further information, or refuse further involvement when the interviewer attempted to make an appointment to visit; when the interviewer visited and at any point during the administration of any elements of the surveys.

Of the approximately 17415 individuals that have ever participated in the study there will always be a number of individuals for whom the Centre for Longitudinal Studies (CLS) at University College London will not have a confirmed addresses at the time of carrying out the next survey. For example, In the most recent tracing exercise conducted with NHS Digital - CLS sent just under 3,500 study members for matching. It is estimated that the number of study members which will be sent for matching in the next exercise will be lower than this.

The ongoing success of the study depends on maintaining contact with as large a number of study members as possible. Therefore, CLS are seeking permission to be supplied with updated addresses for these study members whose whereabouts are currently unknown. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives.

Objective:

Each year CLS sends an annual birthday card postal mailing in March to all NCDS participants. CLS asks that participants complete a ‘reply slip’ which is returned to CLS which allows participants to provide CLS with any change in their details e.g. a new email address, phone number, etc. CLS also ask them to return the reply slip even if none of their details have changed i.e. seeking a positive confirmation that that is the address CLS hold for them.

As a result CLS, can maintain the cohorts' latest details on the NCDS database. In the event of the birthday card not reaching the participant it is returned to CLS as a ‘return to sender’. CLS will attempt to trace all these returns – but if CLS cannot locate the participants then they are flagged on the database as a ‘gone-away’. It is these cases that are being sent to NHS Digital for list cleaning as the NHS may potentially hold a more recent address and provide CLS with an opportunity to invite the cohort to re-join the study.

NHS Digital will supply new addresses for untraced study members who can be matched to the NHS Central Registry/Personal Demographics Service (PDS).

CLS require to trace lost study members between now and the Age 62 survey in 2020 which is currently in the planning stage. Any study members successfully traced via this route would be written to and asked to provide updated contact details. They will then subsequently be invited to participate in the NCDS Age 62 survey (unless they withdraw from the study).

All those the researchers would seek to trace have participated in at least one prior sweep of the study and none have ever informed CLS that they no longer wish to participate in the study. The researchers feel that a substantial number of these individuals would be willing to participate in the study if they could be contacted. Previous efforts to re-establish contact for other cohort studies have been very successful using this route. When the cohort are contacted they will be given the opportunity to withdraw.

Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). Any previously deposited pseudonymised survey data for a study member and confidential data from the address database are retained unless the study member specifically asks CLS not to, in which cases this data is securely deleted. If the participant has died no contact will be made and the study will be updated to reflect this.

For the NCDS Age 62 survey, CLS have contracted an external supplier NatCen Social Research (the trading name of the National Centre for Social Research) to carry out the individual study members' interviews. NatCen have been commissioned to run interviews with study members for the Age 62 Survey. In addition they will conduct a number of pilot studies in the run-up to the launch of the main survey. NatCen have also contracted an additional Data Processor, Kantar Public, to assist with these tasks.

CLS will use Copyprint to distribute annual mailings to all participants. This exercise serves as an additional method of maintaining contact with as many participants between Age surveys.

All processors (mentioned in this application) will have access to participant demographic information and contact details in order to carry out these processes. This includes data which has been supplied by NHS Digital for updated contact information.

Expected output

NCDS is a multidisciplinary cohort study of all babies born in Great Britain in a single week in 1958. The initial birth survey was conducted by midwives in hospitals across Great Britain, comprising a remarkable 98.1% of the target population. Participants have subsequently been followed up at 7, 11, 16, 23, 33, 42, 44/5 (a dedicated biomedical sweep), 46, 50 and 55 years of age. The initial sample of 17,415 individuals was augmented during childhood by immigrants into Great Britain, with a resulting total sample of 18,558.

With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build.

The Age 62 Survey will be comprised of two major components:

1) A core interview which will cover the following topics:

Health, well-being and cognition: physical health, mental health, medical care, health behaviours (e.g. smoking, drinking, diet, exercise), cognitive function.

Finances and employment: work, income, wealth (savings and debts, pensions, & housing), retirement plans & education.

Family, relationships and identity: social networks, relationships with partners, parents, children, friends, neighbourhood, social capital, social and political participation, attitudes and values, and religion.

2) A detailed biomedical assessment including measures of anthropometry, physical functioning, cardiovascular risk factors and a full range of blood tests. The central aim of this biomedical assessment is to enable new research that will inform key public health concerns.

The data collected will be documented, aggregated in line with the HES Analysis Guide, and archived with the UK Data Service in early 2023 to provide a strategically important resource for UK Social Science, including researchers in health and social care.

Outputs of the list clean :

These addresses obtained from NHS Digital will be used to maintain contact with study members e.g. to send them a special birthday mailing for their birthday and then later to invite them to take part in the Age 62 survey. As a result of the previous list clean - CLS was able to update its database with new contact details for 1705 participants who will receive the birthday mailing in March 2019. They will subsequently be invited to participate in the Age 62 Survey, (unless they withdraw from the study).

Benefits reported

Findings from NCDS have repeatedly impacted on policy. Amongst its earliest findings was the discovery that maternal smoking in pregnancy was associated with higher rates of spontaneous abortion, lower birthweight in viable offspring, and reduced cognitive function in childhood which were not, as was suspected, due to confounding by social circumstances. An important part of the study’s history took place in 2002/3—the first and only full adult biomedical at age 44/5. This data collection yielded new insights into the environmental determinants of an array of adult health outcomes, and made a major impact on the understanding of the genetic underpinning of disease through its pioneering role as one of two sets of national ‘healthy’ controls in the Wellcome Trust Case Control Consortium (WTCCC). This data collection has also had a major impact through analyses based on NCDS’s life course data, demonstrating, for example, the life course continuity of psychological distress and its role as a determinant of future social circumstances; the influence of obesity across life on glucose metabolism, diabetes, and raised BP; and the link between lower pre-adult cognitive function and CVD risk factors and widespread pain; and a growing understanding of the pernicious long term effects of early life adversities such as poor social circumstances, experiences of neglect, abuse, and bullying on later impaired pulmonary function, indicators of cumulative physiological damage, inflammation, obesity, and cortisol patterns. Findings on Vitamin D deficiency in midlife led to the initiation of supplementation trials. NCDS has a high scientific output to date, as evidenced by the large number of publications and citations across a wide range of disciplines. In total over 1600 research publications have been produced using NCDS data since 2008 - of which a very significant proportion are focused on aspects of health. Below are some examples of existing publications using NCDS data benefiting public health:

ABO-ZAID, G, SHARPE, R.A., FLEMING, L.E., DEPLEDGE, M and OSBORNE, N.J.. (2018) Association of Infant Eczema with Childhood and Adult Asthma: Analysis of Data from the 1958 Birth Cohort Study. International Journal of Environmental Research and Public Health, 15(7), 1415.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding the relationship between early life eczema and asthma later in life.

Detailed information about the study can be found here:

https://www.mdpi.com/1660-4601/15/7/1415

BANN, D, JOHNSON, W, LI, L, KUH, D and HARDY, R. (2018) Socioeconomic inequalities in childhood and adolescent body-mass index, weight, and height from 1953 to 2015: an analysis of four longitudinal, observational, British birth cohort studies. Lancet Public Health, 3(4), e194-e203.

IMPACT: Research using NCDS Cohort Study data has enabled a long-run investigation of socioeconomic inequalities in BMI, and to more recent data than previously available.

Detailed information about the study can be found here:

https://www.sciencedirect.com/science/article/pii/S2468266718300458?via%3Dihub

BEAUMONT, R.N, WARRINGTON, N.M, CAVADINO, A, TYRRELL, J, NODZENSKI, M, HORIKOSHI, M, GELLER, F, MYHRE, R, RICHMOND, R.C, PATERNOSTER, L, BRADFIELD, J.P, KREINER-MØLLER, E, HUIKARI, V, METRUSTRY, S, LUNETTA, K.L, PAINTER, J.N, HOTTENGA, J-J, ALLARD, C, BARTON, S.J, ESPINOSA, A, MARSH, J.A, POTTER, C, ZHANG, G, ANG, W, BERRY, D.J, BOUCHARD, L, DAS, S, EARLY GROWTH GENETICS (EGG) CONSORTIUM, HAKONARSON, H, HEIKKINEN, J, HELGELAND, Ø, HOCHER, B, HOFMAN, A, INSKIP, H.M, JONES, S.E, KOGEVINAS, M, LIND, P.A, MARULLO, L, MEDLAND, S.E, MURRAY, A, MURRAY, J.C, NJØLSTAD, P.R, NOHR, E.A, REICHETZEDER, C, RING, S.M, RUTH, K.S, SANTA-MARINA, L, SCHOLTENS, D.M, SEBERT, S, SENGPIEL, V, TUKE, M.A, VAUDEL, M, WEEDON, M.N, WILLEMSEN, G, WOOD, A.R, YAGHOOTKAR, H, MUGLIA, L.J, BARTELS, M, RELTON, C.L, PENNELL, C.E, CHATZI, L, ESTIVILL, X, HOLLOWAY, J.W, BOOMSMA, D.I, MONTGOMERY, G.W, MURABITO, J.M, SPECTOR, T.D, POWER, C, JÄRVELIN, M-R, BISGAARD, H, GRANT, S.F, SØRENSEN, T.I, JADDOE, V.W, JACOBSSON, B, MELBYE, M, MCCARTHY, M.I, HATTERSLEY, A.T, HAYES, M.G, FRAYLING, T.M, HIVERT, M-F, FELIX, J.F, HYPPÖNEN, E, LOWE, W.L, EVANS, D.M, LAWLOR, D.A, FEENSTRA, B and FREATHY, R.M. (2018) Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics. Human Molecular Genetics, 27(4), 742-756.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding of the role of maternal genetic variation on fetal birth weight.

Detailed information about the study can be found here:

https://academic.oup.com/hmg/article/27/4/742/4788598

• Power, C., & Matthews, S. (1997). Origins of health inequalities in a national population sample. The Lancet, 350(9091), 1584-1589.

• Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007; 85 (3):860-8.

• Strachan, D.P., 2000. Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax, 55 (Suppl 1), p.S2.

• Clark C, Rodgers B, Caldwell T, Power C, Stansfeld S. Childhood and adulthood psychological ill health as predictors of midlife affective and anxiety disorders: the 1958 British Birth Cohort. Arch Gen Psychiatry. 2007; 64 (6):668-78.

• Orfei L, Strachan DP, Rudnicka AR, Wadsworth M. Early influences on adult lung function in two national British cohorts. Arch Dis Child. 2008; 93 (7):570-4.

• Johnson W, Li L, Kuh D, Hardy R. How Has the Age-Related Process of Overweight or Obesity Development Changed over Time? Co-ordinated Analyses of Individual Participant Data from Five United Kingdom Birth Cohorts. PLoS Med. 2015; 12 (5):e1001828.

DARS-NIC-137864-T1P9B-v3.2 17 April 2020 to 17 January 2022
Title
MR1450 - National Child Development Study (NCDS)
Commercial
No
Sublicensing
No
Datasets
2
Files released
0

Datasets: Demographics; MRIS - List Cleaning Report

What changed from DARS-NIC-137864-T1P9B-v2.7

Text removed is struck through; text added is underlined. Unchanged paragraphs are summarised rather than repeated.

Fields changed from DARS-NIC-137864-T1P9B-v2.7
FieldWasBecame
Start date2019-01-182020-04-17

Datasets: + Demographics

Unchanged: Objective for processing, Processing activities, Expected output, Expected measurable benefits, Benefits reported.

Objective for processing

The National Child Development Study (NCDS) is the second of Britain’s world renowned national longitudinal birth cohort studies. It follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on. The study has its origins in the Perinatal Mortality Survey. Sponsored by the National Birthday Trust Fund, this was designed to examine the social and obstetric factors associated with stillbirth and death in early infancy among the children born in Great Britain in that one week. Information was gathered from 17,415 babies.

Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50 and 55. The next NCDS survey will take place in 2020 when study members will be aged 62.

In 1958, when the birth survey was carried out, consent to participate in surveys was gained by respondents agreeing to be interviewed or respondents returning the completed questionnaire to the study team. Involvement in subsequent surveys adopted the same approach. Individuals could withdraw from the study at any time by simply expressing the wish to do so.

In all recent follow-ups the approach to collecting consent has been very similar. During fieldwork, study members were sent an advance letter advising them about the survey. The letter was accompanied by an information leaflet explaining what is involved. Study members had the opportunity to request further information, or to opt out of the survey at this point. They could also seek further information, or refuse further involvement when the interviewer attempted to make an appointment to visit; when the interviewer visited and at any point during the administration of any elements of the surveys.

Of the approximately 17415 individuals that have ever participated in the study there will always be a number of individuals for whom the Centre for Longitudinal Studies (CLS) at University College London will not have a confirmed addresses at the time of carrying out the next survey. For example, In the most recent tracing exercise conducted with NHS Digital - CLS sent just under 3,500 study members for matching. It is estimated that the number of study members which will be sent for matching in the next exercise will be lower than this.

The ongoing success of the study depends on maintaining contact with as large a number of study members as possible. Therefore, CLS are seeking permission to be supplied with updated addresses for these study members whose whereabouts are currently unknown. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives.

Objective:

Each year CLS sends an annual birthday card postal mailing in March to all NCDS participants. CLS asks that participants complete a ‘reply slip’ which is returned to CLS which allows participants to provide CLS with any change in their details e.g. a new email address, phone number, etc. CLS also ask them to return the reply slip even if none of their details have changed i.e. seeking a positive confirmation that that is the address CLS hold for them.

As a result CLS, can maintain the cohorts' latest details on the NCDS database. In the event of the birthday card not reaching the participant it is returned to CLS as a ‘return to sender’. CLS will attempt to trace all these returns – but if CLS cannot locate the participants then they are flagged on the database as a ‘gone-away’. It is these cases that are being sent to NHS Digital for list cleaning as the NHS may potentially hold a more recent address and provide CLS with an opportunity to invite the cohort to re-join the study.

NHS Digital will supply new addresses for untraced study members who can be matched to the NHS Central Registry/Personal Demographics Service (PDS).

CLS require to trace lost study members between now and the Age 62 survey in 2020 which is currently in the planning stage. Any study members successfully traced via this route would be written to and asked to provide updated contact details. They will then subsequently be invited to participate in the NCDS Age 62 survey (unless they withdraw from the study).

All those the researchers would seek to trace have participated in at least one prior sweep of the study and none have ever informed CLS that they no longer wish to participate in the study. The researchers feel that a substantial number of these individuals would be willing to participate in the study if they could be contacted. Previous efforts to re-establish contact for other cohort studies have been very successful using this route. When the cohort are contacted they will be given the opportunity to withdraw.

Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). Any previously deposited pseudonymised survey data for a study member and confidential data from the address database are retained unless the study member specifically asks CLS not to, in which cases this data is securely deleted. If the participant has died no contact will be made and the study will be updated to reflect this.

For the NCDS Age 62 survey, CLS have contracted an external supplier NatCen Social Research (the trading name of the National Centre for Social Research) to carry out the individual study members' interviews. NatCen have been commissioned to run interviews with study members for the Age 62 Survey. In addition they will conduct a number of pilot studies in the run-up to the launch of the main survey. NatCen have also contracted an additional Data Processor, Kantar Public, to assist with these tasks.

CLS will use Copyprint to distribute annual mailings to all participants. This exercise serves as an additional method of maintaining contact with as many participants between Age surveys.

All processors (mentioned in this application) will have access to participant demographic information and contact details in order to carry out these processes. This includes data which has been supplied by NHS Digital for updated contact information.

Expected output

NCDS is a multidisciplinary cohort study of all babies born in Great Britain in a single week in 1958. The initial birth survey was conducted by midwives in hospitals across Great Britain, comprising a remarkable 98.1% of the target population. Participants have subsequently been followed up at 7, 11, 16, 23, 33, 42, 44/5 (a dedicated biomedical sweep), 46, 50 and 55 years of age. The initial sample of 17,415 individuals was augmented during childhood by immigrants into Great Britain, with a resulting total sample of 18,558.

With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build.

The Age 62 Survey will be comprised of two major components:

1) A core interview which will cover the following topics:

Health, well-being and cognition: physical health, mental health, medical care, health behaviours (e.g. smoking, drinking, diet, exercise), cognitive function.

Finances and employment: work, income, wealth (savings and debts, pensions, & housing), retirement plans & education.

Family, relationships and identity: social networks, relationships with partners, parents, children, friends, neighbourhood, social capital, social and political participation, attitudes and values, and religion.

2) A detailed biomedical assessment including measures of anthropometry, physical functioning, cardiovascular risk factors and a full range of blood tests. The central aim of this biomedical assessment is to enable new research that will inform key public health concerns.

The data collected will be documented, aggregated in line with the HES Analysis Guide, and archived with the UK Data Service in early 2023 to provide a strategically important resource for UK Social Science, including researchers in health and social care.

Outputs of the list clean :

These addresses obtained from NHS Digital will be used to maintain contact with study members e.g. to send them a special birthday mailing for their birthday and then later to invite them to take part in the Age 62 survey. As a result of the previous list clean - CLS was able to update its database with new contact details for 1705 participants who will receive the birthday mailing in March 2019. They will subsequently be invited to participate in the Age 62 Survey, (unless they withdraw from the study).

Benefits reported

Findings from NCDS have repeatedly impacted on policy. Amongst its earliest findings was the discovery that maternal smoking in pregnancy was associated with higher rates of spontaneous abortion, lower birthweight in viable offspring, and reduced cognitive function in childhood which were not, as was suspected, due to confounding by social circumstances. An important part of the study’s history took place in 2002/3—the first and only full adult biomedical at age 44/5. This data collection yielded new insights into the environmental determinants of an array of adult health outcomes, and made a major impact on the understanding of the genetic underpinning of disease through its pioneering role as one of two sets of national ‘healthy’ controls in the Wellcome Trust Case Control Consortium (WTCCC). This data collection has also had a major impact through analyses based on NCDS’s life course data, demonstrating, for example, the life course continuity of psychological distress and its role as a determinant of future social circumstances; the influence of obesity across life on glucose metabolism, diabetes, and raised BP; and the link between lower pre-adult cognitive function and CVD risk factors and widespread pain; and a growing understanding of the pernicious long term effects of early life adversities such as poor social circumstances, experiences of neglect, abuse, and bullying on later impaired pulmonary function, indicators of cumulative physiological damage, inflammation, obesity, and cortisol patterns. Findings on Vitamin D deficiency in midlife led to the initiation of supplementation trials. NCDS has a high scientific output to date, as evidenced by the large number of publications and citations across a wide range of disciplines. In total over 1600 research publications have been produced using NCDS data since 2008 - of which a very significant proportion are focused on aspects of health. Below are some examples of existing publications using NCDS data benefiting public health:

ABO-ZAID, G, SHARPE, R.A., FLEMING, L.E., DEPLEDGE, M and OSBORNE, N.J.. (2018) Association of Infant Eczema with Childhood and Adult Asthma: Analysis of Data from the 1958 Birth Cohort Study. International Journal of Environmental Research and Public Health, 15(7), 1415.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding the relationship between early life eczema and asthma later in life.

Detailed information about the study can be found here:

https://www.mdpi.com/1660-4601/15/7/1415

BANN, D, JOHNSON, W, LI, L, KUH, D and HARDY, R. (2018) Socioeconomic inequalities in childhood and adolescent body-mass index, weight, and height from 1953 to 2015: an analysis of four longitudinal, observational, British birth cohort studies. Lancet Public Health, 3(4), e194-e203.

IMPACT: Research using NCDS Cohort Study data has enabled a long-run investigation of socioeconomic inequalities in BMI, and to more recent data than previously available.

Detailed information about the study can be found here:

https://www.sciencedirect.com/science/article/pii/S2468266718300458?via%3Dihub

BEAUMONT, R.N, WARRINGTON, N.M, CAVADINO, A, TYRRELL, J, NODZENSKI, M, HORIKOSHI, M, GELLER, F, MYHRE, R, RICHMOND, R.C, PATERNOSTER, L, BRADFIELD, J.P, KREINER-MØLLER, E, HUIKARI, V, METRUSTRY, S, LUNETTA, K.L, PAINTER, J.N, HOTTENGA, J-J, ALLARD, C, BARTON, S.J, ESPINOSA, A, MARSH, J.A, POTTER, C, ZHANG, G, ANG, W, BERRY, D.J, BOUCHARD, L, DAS, S, EARLY GROWTH GENETICS (EGG) CONSORTIUM, HAKONARSON, H, HEIKKINEN, J, HELGELAND, Ø, HOCHER, B, HOFMAN, A, INSKIP, H.M, JONES, S.E, KOGEVINAS, M, LIND, P.A, MARULLO, L, MEDLAND, S.E, MURRAY, A, MURRAY, J.C, NJØLSTAD, P.R, NOHR, E.A, REICHETZEDER, C, RING, S.M, RUTH, K.S, SANTA-MARINA, L, SCHOLTENS, D.M, SEBERT, S, SENGPIEL, V, TUKE, M.A, VAUDEL, M, WEEDON, M.N, WILLEMSEN, G, WOOD, A.R, YAGHOOTKAR, H, MUGLIA, L.J, BARTELS, M, RELTON, C.L, PENNELL, C.E, CHATZI, L, ESTIVILL, X, HOLLOWAY, J.W, BOOMSMA, D.I, MONTGOMERY, G.W, MURABITO, J.M, SPECTOR, T.D, POWER, C, JÄRVELIN, M-R, BISGAARD, H, GRANT, S.F, SØRENSEN, T.I, JADDOE, V.W, JACOBSSON, B, MELBYE, M, MCCARTHY, M.I, HATTERSLEY, A.T, HAYES, M.G, FRAYLING, T.M, HIVERT, M-F, FELIX, J.F, HYPPÖNEN, E, LOWE, W.L, EVANS, D.M, LAWLOR, D.A, FEENSTRA, B and FREATHY, R.M. (2018) Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics. Human Molecular Genetics, 27(4), 742-756.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding of the role of maternal genetic variation on fetal birth weight.

Detailed information about the study can be found here:

https://academic.oup.com/hmg/article/27/4/742/4788598

• Power, C., & Matthews, S. (1997). Origins of health inequalities in a national population sample. The Lancet, 350(9091), 1584-1589.

• Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007; 85 (3):860-8.

• Strachan, D.P., 2000. Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax, 55 (Suppl 1), p.S2.

• Clark C, Rodgers B, Caldwell T, Power C, Stansfeld S. Childhood and adulthood psychological ill health as predictors of midlife affective and anxiety disorders: the 1958 British Birth Cohort. Arch Gen Psychiatry. 2007; 64 (6):668-78.

• Orfei L, Strachan DP, Rudnicka AR, Wadsworth M. Early influences on adult lung function in two national British cohorts. Arch Dis Child. 2008; 93 (7):570-4.

• Johnson W, Li L, Kuh D, Hardy R. How Has the Age-Related Process of Overweight or Obesity Development Changed over Time? Co-ordinated Analyses of Individual Participant Data from Five United Kingdom Birth Cohorts. PLoS Med. 2015; 12 (5):e1001828.

DARS-NIC-137864-T1P9B-v2.7 18 January 2019 to 17 January 2022
Title
MR1450 - National Child Development Study (NCDS)
Commercial
No
Sublicensing
No
Datasets
1
Files released
0

Datasets: MRIS - List Cleaning Report

Objective for processing

The National Child Development Study (NCDS) is the second of Britain’s world renowned national longitudinal birth cohort studies. It follows all those born in one week in 1958 through the course of their lives, charting the effects of experiences in early life on outcomes and achievements later on. The study has its origins in the Perinatal Mortality Survey. Sponsored by the National Birthday Trust Fund, this was designed to examine the social and obstetric factors associated with stillbirth and death in early infancy among the children born in Great Britain in that one week. Information was gathered from 17,415 babies.

Since 1958 information has been gathered from the NCDS cohort on nine occasions. Over time, the scope of enquiry has broadened from a strictly medical focus at birth, to encompass physical and educational development at the age of seven, physical, educational and social development at the ages of eleven and sixteen, and then to include economic development and other wider factors at ages 23, 33, 42, 44, 46, 50 and 55. The next NCDS survey will take place in 2020 when study members will be aged 62.

In 1958, when the birth survey was carried out, consent to participate in surveys was gained by respondents agreeing to be interviewed or respondents returning the completed questionnaire to the study team. Involvement in subsequent surveys adopted the same approach. Individuals could withdraw from the study at any time by simply expressing the wish to do so.

In all recent follow-ups the approach to collecting consent has been very similar. During fieldwork, study members were sent an advance letter advising them about the survey. The letter was accompanied by an information leaflet explaining what is involved. Study members had the opportunity to request further information, or to opt out of the survey at this point. They could also seek further information, or refuse further involvement when the interviewer attempted to make an appointment to visit; when the interviewer visited and at any point during the administration of any elements of the surveys.

Of the approximately 17415 individuals that have ever participated in the study there will always be a number of individuals for whom the Centre for Longitudinal Studies (CLS) at University College London will not have a confirmed addresses at the time of carrying out the next survey. For example, In the most recent tracing exercise conducted with NHS Digital - CLS sent just under 3,500 study members for matching. It is estimated that the number of study members which will be sent for matching in the next exercise will be lower than this.

The ongoing success of the study depends on maintaining contact with as large a number of study members as possible. Therefore, CLS are seeking permission to be supplied with updated addresses for these study members whose whereabouts are currently unknown. All of these individuals have made an informed decision to participate in the study over the years and have been made aware that the study is seeking to follow them throughout their lives.

Objective:

Each year CLS sends an annual birthday card postal mailing in March to all NCDS participants. CLS asks that participants complete a ‘reply slip’ which is returned to CLS which allows participants to provide CLS with any change in their details e.g. a new email address, phone number, etc. CLS also ask them to return the reply slip even if none of their details have changed i.e. seeking a positive confirmation that that is the address CLS hold for them.

As a result CLS, can maintain the cohorts' latest details on the NCDS database. In the event of the birthday card not reaching the participant it is returned to CLS as a ‘return to sender’. CLS will attempt to trace all these returns – but if CLS cannot locate the participants then they are flagged on the database as a ‘gone-away’. It is these cases that are being sent to NHS Digital for list cleaning as the NHS may potentially hold a more recent address and provide CLS with an opportunity to invite the cohort to re-join the study.

NHS Digital will supply new addresses for untraced study members who can be matched to the NHS Central Registry/Personal Demographics Service (PDS).

CLS require to trace lost study members between now and the Age 62 survey in 2020 which is currently in the planning stage. Any study members successfully traced via this route would be written to and asked to provide updated contact details. They will then subsequently be invited to participate in the NCDS Age 62 survey (unless they withdraw from the study).

All those the researchers would seek to trace have participated in at least one prior sweep of the study and none have ever informed CLS that they no longer wish to participate in the study. The researchers feel that a substantial number of these individuals would be willing to participate in the study if they could be contacted. Previous efforts to re-establish contact for other cohort studies have been very successful using this route. When the cohort are contacted they will be given the opportunity to withdraw.

Any study members choosing not to take part in the study are flagged on the secure confidential address database at the CLS with a code denoting whether their refusal is temporary (i.e. for a particular wave/survey) or permanent (i.e. they wish to have no further involvement in the study). Any previously deposited pseudonymised survey data for a study member and confidential data from the address database are retained unless the study member specifically asks CLS not to, in which cases this data is securely deleted. If the participant has died no contact will be made and the study will be updated to reflect this.

For the NCDS Age 62 survey, CLS have contracted an external supplier NatCen Social Research (the trading name of the National Centre for Social Research) to carry out the individual study members' interviews. NatCen have been commissioned to run interviews with study members for the Age 62 Survey. In addition they will conduct a number of pilot studies in the run-up to the launch of the main survey. NatCen have also contracted an additional Data Processor, Kantar Public, to assist with these tasks.

CLS will use Copyprint to distribute annual mailings to all participants. This exercise serves as an additional method of maintaining contact with as many participants between Age surveys.

All processors (mentioned in this application) will have access to participant demographic information and contact details in order to carry out these processes. This includes data which has been supplied by NHS Digital for updated contact information.

Expected output

NCDS is a multidisciplinary cohort study of all babies born in Great Britain in a single week in 1958. The initial birth survey was conducted by midwives in hospitals across Great Britain, comprising a remarkable 98.1% of the target population. Participants have subsequently been followed up at 7, 11, 16, 23, 33, 42, 44/5 (a dedicated biomedical sweep), 46, 50 and 55 years of age. The initial sample of 17,415 individuals was augmented during childhood by immigrants into Great Britain, with a resulting total sample of 18,558.

With 9,790 study members interviewed at the last face-to-face interview in 2008 and 9,137 in the online and telephone survey in 2013, the NCDS is the largest of the UK’s adult national birth cohort studies. The sample is nationally representative. The study’s content spans the biomedical and social sciences, with high quality prospective data on social, biological, physical, and psychological phenotypes at each sweep, including from survey instruments, objective measures and via economic and health record linkage consent. The study has benefitted from sustained scientific and infrastructural investment over many decades, including, in 2002/3, an MRC-funded first biomedical sweep when cohort members were age 44/5, one of the primary goals of which was to serve as a baseline for the future study of ageing, and on which the Age 62 Survey will now build.

The Age 62 Survey will be comprised of two major components:

1) A core interview which will cover the following topics:

Health, well-being and cognition: physical health, mental health, medical care, health behaviours (e.g. smoking, drinking, diet, exercise), cognitive function.

Finances and employment: work, income, wealth (savings and debts, pensions, & housing), retirement plans & education.

Family, relationships and identity: social networks, relationships with partners, parents, children, friends, neighbourhood, social capital, social and political participation, attitudes and values, and religion.

2) A detailed biomedical assessment including measures of anthropometry, physical functioning, cardiovascular risk factors and a full range of blood tests. The central aim of this biomedical assessment is to enable new research that will inform key public health concerns.

The data collected will be documented, aggregated in line with the HES Analysis Guide, and archived with the UK Data Service in early 2023 to provide a strategically important resource for UK Social Science, including researchers in health and social care.

Outputs of the list clean :

These addresses obtained from NHS Digital will be used to maintain contact with study members e.g. to send them a special birthday mailing for their birthday and then later to invite them to take part in the Age 62 survey. As a result of the previous list clean - CLS was able to update its database with new contact details for 1705 participants who will receive the birthday mailing in March 2019. They will subsequently be invited to participate in the Age 62 Survey, (unless they withdraw from the study).

Benefits reported

Findings from NCDS have repeatedly impacted on policy. Amongst its earliest findings was the discovery that maternal smoking in pregnancy was associated with higher rates of spontaneous abortion, lower birthweight in viable offspring, and reduced cognitive function in childhood which were not, as was suspected, due to confounding by social circumstances. An important part of the study’s history took place in 2002/3—the first and only full adult biomedical at age 44/5. This data collection yielded new insights into the environmental determinants of an array of adult health outcomes, and made a major impact on the understanding of the genetic underpinning of disease through its pioneering role as one of two sets of national ‘healthy’ controls in the Wellcome Trust Case Control Consortium (WTCCC). This data collection has also had a major impact through analyses based on NCDS’s life course data, demonstrating, for example, the life course continuity of psychological distress and its role as a determinant of future social circumstances; the influence of obesity across life on glucose metabolism, diabetes, and raised BP; and the link between lower pre-adult cognitive function and CVD risk factors and widespread pain; and a growing understanding of the pernicious long term effects of early life adversities such as poor social circumstances, experiences of neglect, abuse, and bullying on later impaired pulmonary function, indicators of cumulative physiological damage, inflammation, obesity, and cortisol patterns. Findings on Vitamin D deficiency in midlife led to the initiation of supplementation trials. NCDS has a high scientific output to date, as evidenced by the large number of publications and citations across a wide range of disciplines. In total over 1600 research publications have been produced using NCDS data since 2008 - of which a very significant proportion are focused on aspects of health. Below are some examples of existing publications using NCDS data benefiting public health:

ABO-ZAID, G, SHARPE, R.A., FLEMING, L.E., DEPLEDGE, M and OSBORNE, N.J.. (2018) Association of Infant Eczema with Childhood and Adult Asthma: Analysis of Data from the 1958 Birth Cohort Study. International Journal of Environmental Research and Public Health, 15(7), 1415.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding the relationship between early life eczema and asthma later in life.

Detailed information about the study can be found here:

https://www.mdpi.com/1660-4601/15/7/1415

BANN, D, JOHNSON, W, LI, L, KUH, D and HARDY, R. (2018) Socioeconomic inequalities in childhood and adolescent body-mass index, weight, and height from 1953 to 2015: an analysis of four longitudinal, observational, British birth cohort studies. Lancet Public Health, 3(4), e194-e203.

IMPACT: Research using NCDS Cohort Study data has enabled a long-run investigation of socioeconomic inequalities in BMI, and to more recent data than previously available.

Detailed information about the study can be found here:

https://www.sciencedirect.com/science/article/pii/S2468266718300458?via%3Dihub

BEAUMONT, R.N, WARRINGTON, N.M, CAVADINO, A, TYRRELL, J, NODZENSKI, M, HORIKOSHI, M, GELLER, F, MYHRE, R, RICHMOND, R.C, PATERNOSTER, L, BRADFIELD, J.P, KREINER-MØLLER, E, HUIKARI, V, METRUSTRY, S, LUNETTA, K.L, PAINTER, J.N, HOTTENGA, J-J, ALLARD, C, BARTON, S.J, ESPINOSA, A, MARSH, J.A, POTTER, C, ZHANG, G, ANG, W, BERRY, D.J, BOUCHARD, L, DAS, S, EARLY GROWTH GENETICS (EGG) CONSORTIUM, HAKONARSON, H, HEIKKINEN, J, HELGELAND, Ø, HOCHER, B, HOFMAN, A, INSKIP, H.M, JONES, S.E, KOGEVINAS, M, LIND, P.A, MARULLO, L, MEDLAND, S.E, MURRAY, A, MURRAY, J.C, NJØLSTAD, P.R, NOHR, E.A, REICHETZEDER, C, RING, S.M, RUTH, K.S, SANTA-MARINA, L, SCHOLTENS, D.M, SEBERT, S, SENGPIEL, V, TUKE, M.A, VAUDEL, M, WEEDON, M.N, WILLEMSEN, G, WOOD, A.R, YAGHOOTKAR, H, MUGLIA, L.J, BARTELS, M, RELTON, C.L, PENNELL, C.E, CHATZI, L, ESTIVILL, X, HOLLOWAY, J.W, BOOMSMA, D.I, MONTGOMERY, G.W, MURABITO, J.M, SPECTOR, T.D, POWER, C, JÄRVELIN, M-R, BISGAARD, H, GRANT, S.F, SØRENSEN, T.I, JADDOE, V.W, JACOBSSON, B, MELBYE, M, MCCARTHY, M.I, HATTERSLEY, A.T, HAYES, M.G, FRAYLING, T.M, HIVERT, M-F, FELIX, J.F, HYPPÖNEN, E, LOWE, W.L, EVANS, D.M, LAWLOR, D.A, FEENSTRA, B and FREATHY, R.M. (2018) Genome-wide association study of offspring birth weight in 86,577 women identifies five novel loci and highlights maternal genetic effects that are independent of fetal genetics. Human Molecular Genetics, 27(4), 742-756.

IMPACT: Research using NCDS Cohort Study data has contributed to better understanding of the role of maternal genetic variation on fetal birth weight.

Detailed information about the study can be found here:

https://academic.oup.com/hmg/article/27/4/742/4788598

• Power, C., & Matthews, S. (1997). Origins of health inequalities in a national population sample. The Lancet, 350(9091), 1584-1589.

• Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007; 85 (3):860-8.

• Strachan, D.P., 2000. Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax, 55 (Suppl 1), p.S2.

• Clark C, Rodgers B, Caldwell T, Power C, Stansfeld S. Childhood and adulthood psychological ill health as predictors of midlife affective and anxiety disorders: the 1958 British Birth Cohort. Arch Gen Psychiatry. 2007; 64 (6):668-78.

• Orfei L, Strachan DP, Rudnicka AR, Wadsworth M. Early influences on adult lung function in two national British cohorts. Arch Dis Child. 2008; 93 (7):570-4.

• Johnson W, Li L, Kuh D, Hardy R. How Has the Age-Related Process of Overweight or Obesity Development Changed over Time? Co-ordinated Analyses of Individual Participant Data from Five United Kingdom Birth Cohorts. PLoS Med. 2015; 12 (5):e1001828.

Register history

When this agreement appeared in, or was edited in, each monthly edition of the register. Built by comparing every edition this site holds, the earliest of which is July 2021.

Cite this page

NHS England (2026) Data Uses Register, September 2026 edition, agreement DARS-NIC-137864-T1P9B, “National Child Development Study (NCDS)- Tracing”. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/agreements/dars-nic-137864-t1p9b/ (accessed [date]).

This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.

Source: datausesregister_september2026.xlsx, September 2026 edition of the NHS England Data Uses Register. Search that workbook for DARS-NIC-137864-T1P9B to see the original rows.